Document Name: role of ABIL Wax 2434 in Cold Cream4
Document link: https://patents.google.com/patent/US20040067206A1/en



US20040067206A1 - Skin oils consisting of oil-soluble constituents and w/o-emulsifiers having an hlb value of between 2 and 6 and optionally at least one standard additive, method for the production thereof and use of the same 
        - Google Patents



































US20040067206A1 - Skin oils consisting of oil-soluble constituents and w/o-emulsifiers having an hlb value of between 2 and 6 and optionally at least one standard additive, method for the production thereof and use of the same 
        - Google Patents
Skin oils consisting of oil-soluble constituents and w/o-emulsifiers having an hlb value of between 2 and 6 and optionally at least one standard additive, method for the production thereof and use of the same 
       

Download PDF
Info

Publication number
US20040067206A1



US20040067206A1
US10/450,542
US45054203A
US2004067206A1
US 20040067206 A1
US20040067206 A1
US 20040067206A1
 
 
 
US 45054203 A
US45054203 A
US 45054203A
US 2004067206 A1
US2004067206 A1
US 2004067206A1
Authority
US
United States
Prior art keywords
oil
skin
oils
emulsifier
chosen
Prior art date
2000-12-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned


Application number
US10/450,542
Inventor
Valentina Paspaleeva-Kuhn
Simone Schatschneider
Rolf Beutler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

    Merz Pharma GmbH and Co KGaA
  
Original Assignee
Merz Pharma GmbH and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2000-12-15
Filing date
2001-11-02
Publication date
2004-04-08


Priority claimed from DE10062611.4
external-priority


2001-11-02
Application filed by Merz Pharma GmbH and Co KGaA
filed
Critical
Merz Pharma GmbH and Co KGaA


2003-10-31
Assigned to MERZ PHARMA GMBH & CO. KGAA
reassignment
MERZ PHARMA GMBH & CO. KGAA
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors: BEUTLER, ROLF, PASPALEEVA-KUHN, VALENTINA, SCHATSCHNEIDER, SIMONE


2004-04-08
Publication of US20040067206A1
publication
Critical
patent/US20040067206A1/en


Status
Abandoned
legal-status
Critical
Current

Links



USPTO



USPTO PatentCenter



USPTO Assignment



Espacenet



Global Dossier



Discuss




239000003921
oil
Substances




0.000
title
claims
abstract
description
274


210000003491
Skin
Anatomy




0.000
title
claims
abstract
description
124


239000003995
emulsifying agent
Substances




0.000
title
claims
abstract
description
72


239000000654
additive
Substances




0.000
title
claims
abstract
description
46


230000000996
additive
Effects




0.000
title
claims
abstract
description
12


239000000470
constituent
Substances




0.000
title
abstract
description
6


238000004519
manufacturing process
Methods




0.000
title
abstract
4


239000000126
substance
Substances




0.000
claims
abstract
description
48


239000004480
active ingredient
Substances




0.000
claims
abstract
description
34


229940029983
VITAMINS
Drugs




0.000
claims
abstract
description
26


229940021016
Vitamin IV solution additives
Drugs




0.000
claims
abstract
description
26


235000013343
vitamin
Nutrition




0.000
claims
abstract
description
26


239000011782
vitamin
Substances




0.000
claims
abstract
description
26


229930003231
vitamins
Natural products




0.000
claims
abstract
description
26


239000000341
volatile oil
Substances




0.000
claims
abstract
description
26


230000002335
preservative
Effects




0.000
claims
abstract
description
24


239000003755
preservative agent
Substances




0.000
claims
abstract
description
24


239000004904
UV filter
Substances




0.000
claims
abstract
description
20


230000000111
anti-oxidant
Effects




0.000
claims
abstract
description
20


239000003963
antioxidant agent
Substances




0.000
claims
abstract
description
20


239000002904
solvent
Substances




0.000
claims
abstract
description
14


235000019198
oils
Nutrition




0.000
claims
description
256


239000000203
mixture
Substances




0.000
claims
description
112


-1
polyol esters
Chemical class




0.000
claims
description
88


239000007788
liquid
Substances




0.000
claims
description
46


239000002304
perfume
Substances




0.000
claims
description
36


LFQSCWFLJHTTHZ-UHFFFAOYSA-N
ethanol
Chemical compound


CCO
LFQSCWFLJHTTHZ-UHFFFAOYSA-N
0.000
claims
description
34


235000014113
dietary fatty acids
Nutrition




0.000
claims
description
26


239000000194
fatty acid
Substances




0.000
claims
description
26


239000001993
wax
Substances




0.000
claims
description
26


239000004166
Lanolin
Substances




0.000
claims
description
22


235000019388
lanolin
Nutrition




0.000
claims
description
22


HVYWMOMLDIMFJA-DPAQBDIFSA-N
(3Î²)-Cholest-5-en-3-ol
Chemical compound


C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2
HVYWMOMLDIMFJA-DPAQBDIFSA-N
0.000
claims
description
20


235000006708
antioxidants
Nutrition




0.000
claims
description
18


229940085262
Cetyl dimethicone
Drugs




0.000
claims
description
16


235000006040
Prunus persica var persica
Nutrition




0.000
claims
description
16


229920001296
polysiloxane
Polymers




0.000
claims
description
16


XUGNVMKQXJXZCD-UHFFFAOYSA-N
Isopropyl palmitate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OC(C)C
XUGNVMKQXJXZCD-UHFFFAOYSA-N
0.000
claims
description
14


239000003925
fat
Substances




0.000
claims
description
14


229940075495
isopropyl palmitate
Drugs




0.000
claims
description
14


239000000419
plant extract
Substances




0.000
claims
description
14


229920005862
polyol
Polymers




0.000
claims
description
14


238000002360
preparation method
Methods




0.000
claims
description
14


150000003626
triacylglycerols
Chemical class




0.000
claims
description
14


FPIPGXGPPPQFEQ-OVSJKPMPSA-N
all-trans-retinol
Chemical compound


OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
FPIPGXGPPPQFEQ-OVSJKPMPSA-N
0.000
claims
description
12


239000000975
dye
Substances




0.000
claims
description
12


229940119170
jojoba wax
Drugs




0.000
claims
description
12


229920002545
silicone oil
Polymers




0.000
claims
description
12


230000000475
sunscreen
Effects




0.000
claims
description
12


239000000516
sunscreening agent
Substances




0.000
claims
description
12


229940107161
Cholesterol
Drugs




0.000
claims
description
10


LXCFILQKKLGQFO-UHFFFAOYSA-N
Methylparaben
Chemical compound


COC(=O)C1=CC=C(O)C=C1
LXCFILQKKLGQFO-UHFFFAOYSA-N
0.000
claims
description
10


235000012000
cholesterol
Nutrition




0.000
claims
description
10


150000002303
glucose derivatives
Chemical class




0.000
claims
description
10


230000000051
modifying
Effects




0.000
claims
description
10


229960003471
retinol
Drugs




0.000
claims
description
10


244000144730
Amygdalus persica
Species




0.000
claims
description
8


JNYAEWCLZODPBN-CTQIIAAMSA-N
Sorbitan
Chemical class


OCC(O)C1OCC(O)[C@@H]1O
JNYAEWCLZODPBN-CTQIIAAMSA-N
0.000
claims
description
8


229960001295
Tocopherol
Drugs




0.000
claims
description
8


FPIPGXGPPPQFEQ-BOOMUCAASA-N
Vitamin A
Natural products


OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C
FPIPGXGPPPQFEQ-BOOMUCAASA-N
0.000
claims
description
8


229940045997
Vitamin A
Drugs




0.000
claims
description
8


239000003795
chemical substances by application
Substances




0.000
claims
description
8


150000002191
fatty alcohols
Chemical class




0.000
claims
description
8


229920000642
polymer
Polymers




0.000
claims
description
8


125000005373
siloxane group
Chemical group


[SiH2](O*)*

0.000
claims
description
8


239000011732
tocopherol
Substances




0.000
claims
description
8


235000010384
tocopherol
Nutrition




0.000
claims
description
8


229930003799
tocopherols
Natural products




0.000
claims
description
8


235000019155
vitamin A
Nutrition




0.000
claims
description
8


239000011719
vitamin A
Substances




0.000
claims
description
8


GVJHHUAWPYXKBD-IEOSBIPESA-N
Î±-tocopherol
Chemical compound


OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C
GVJHHUAWPYXKBD-IEOSBIPESA-N
0.000
claims
description
8


WXZMFSXDPGVJKK-UHFFFAOYSA-N
2,2-bis(hydroxymethyl)propane-1,3-diol
Chemical class


OCC(CO)(CO)CO
WXZMFSXDPGVJKK-UHFFFAOYSA-N
0.000
claims
description
6


229940100518
POLYGLYCERYL-4 ISOSTEARATE
Drugs




0.000
claims
description
6


QELSKZZBTMNZEB-UHFFFAOYSA-N
Propylparaben
Chemical compound


CCCOC(=O)C1=CC=C(O)C=C1
QELSKZZBTMNZEB-UHFFFAOYSA-N
0.000
claims
description
6


235000019486
Sunflower oil
Nutrition




0.000
claims
description
6


229930003268
Vitamin C
Natural products




0.000
claims
description
6


229930003427
Vitamin E
Natural products




0.000
claims
description
6


230000000844
anti-bacterial
Effects




0.000
claims
description
6


230000001741
anti-phlogistic
Effects




0.000
claims
description
6


CMBYOWLFQAFZCP-UHFFFAOYSA-N
hexyl dodecanoate
Chemical compound


CCCCCCCCCCCC(=O)OCCCCCC
CMBYOWLFQAFZCP-UHFFFAOYSA-N
0.000
claims
description
6


229940100463
hexyl laurate
Drugs




0.000
claims
description
6


150000002430
hydrocarbons
Chemical class




0.000
claims
description
6


239000004292
methyl p-hydroxybenzoate
Substances




0.000
claims
description
6


235000010270
methyl p-hydroxybenzoate
Nutrition




0.000
claims
description
6


229960002216
methylparaben
Drugs




0.000
claims
description
6


239000004405
propyl p-hydroxybenzoate
Substances




0.000
claims
description
6


235000010232
propyl p-hydroxybenzoate
Nutrition




0.000
claims
description
6


229960003415
propylparaben
Drugs




0.000
claims
description
6


239000003549
soybean oil
Substances




0.000
claims
description
6


235000012424
soybean oil
Nutrition




0.000
claims
description
6


239000002600
sunflower oil
Substances




0.000
claims
description
6


150000003505
terpenes
Chemical class




0.000
claims
description
6


235000007586
terpenes
Nutrition




0.000
claims
description
6


235000019154
vitamin C
Nutrition




0.000
claims
description
6


239000011718
vitamin C
Substances




0.000
claims
description
6


150000003700
vitamin C derivatives
Chemical class




0.000
claims
description
6


235000019165
vitamin E
Nutrition




0.000
claims
description
6


239000011709
vitamin E
Substances




0.000
claims
description
6


150000003712
vitamin E derivatives
Chemical class




0.000
claims
description
6


CZBZUDVBLSSABA-UHFFFAOYSA-N
Butylated hydroxyanisole
Chemical compound


COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C
CZBZUDVBLSSABA-UHFFFAOYSA-N
0.000
claims
description
4


NLZUEZXRPGMBCV-UHFFFAOYSA-N
Butylhydroxytoluene
Chemical compound


CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1
NLZUEZXRPGMBCV-UHFFFAOYSA-N
0.000
claims
description
4


QAQJMLQRFWZOBN-LAUBAEHRSA-N
L-ascorbyl-6-palmitate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
QAQJMLQRFWZOBN-LAUBAEHRSA-N
0.000
claims
description
4


239000011786
L-ascorbyl-6-palmitate
Substances




0.000
claims
description
4


229940057917
Medium chain triglycerides
Drugs




0.000
claims
description
4


229940046009
Vitamin E
Drugs




0.000
claims
description
4


235000010385
ascorbyl palmitate
Nutrition




0.000
claims
description
4


125000005908
glyceryl ester group
Chemical group




0.000
claims
description
4


125000003976
glyceryl group
Chemical group


[H]C([*])([H])C(O[H])([H])C(O[H])([H])[H]

0.000
claims
description
4


238000000034
method
Methods




0.000
claims
description
4


230000002195
synergetic
Effects




0.000
claims
description
4


150000003722
vitamin derivatives
Chemical class




0.000
claims
description
4


239000010477
apricot oil
Substances




0.000
claims
2


229940057995
liquid paraffin
Drugs




0.000
claims
2


239000002562
thickening agent
Substances




0.000
abstract
description
6


206010013786
Dry skin
Diseases




0.000
abstract
description
4


230000037336
dry skin
Effects




0.000
abstract
description
4


238000002791
soaking
Methods




0.000
abstract
2


229940060184
oil ingredients
Drugs




0.000
description
138


BARWIPMJPCRCTP-CLFAGFIQSA-N
oleyl oleate
Chemical compound


CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC
BARWIPMJPCRCTP-CLFAGFIQSA-N
0.000
description
26


WSSJONWNBBTCMG-UHFFFAOYSA-N
Homosalate
Chemical compound


C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O
WSSJONWNBBTCMG-UHFFFAOYSA-N
0.000
description
20


150000002148
esters
Chemical class




0.000
description
20


239000000284
extract
Substances




0.000
description
20


229940039717
Lanolin
Drugs




0.000
description
14


239000005662
Paraffin oil
Substances




0.000
description
14


230000000694
effects
Effects




0.000
description
14


CWLGEPSKQDNHIO-JOBJLJCHSA-N
(E)-N-[(E)-benzylideneamino]-1-phenylmethanimine
Chemical compound


C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1
CWLGEPSKQDNHIO-JOBJLJCHSA-N
0.000
description
12


RNNBHZYEKNHLKT-UHFFFAOYSA-N
Isopropylmethylpyrazolyl dimethylcarbamate
Chemical compound


CC(C)N1N=C(C)C=C1OC(=O)N(C)C
RNNBHZYEKNHLKT-UHFFFAOYSA-N
0.000
description
12


RTZKZFJDLAIYFH-UHFFFAOYSA-N
diethyl ether
Chemical compound


CCOCC
RTZKZFJDLAIYFH-UHFFFAOYSA-N
0.000
description
12


235000013870
dimethyl polysiloxane
Nutrition




0.000
description
12


235000019197
fats
Nutrition




0.000
description
12


YNBADRVTZLEFNH-UHFFFAOYSA-N
methyl pyridine-3-carboxylate
Chemical compound


COC(=O)C1=CC=CN=C1
YNBADRVTZLEFNH-UHFFFAOYSA-N
0.000
description
12


229920000435
poly(dimethylsiloxane)
Polymers




0.000
description
12


239000010668
rosemary oil
Substances




0.000
description
12


229940058206
rosemary oil
Drugs




0.000
description
12


ZAKOWWREFLAJOT-CEFNRUSXSA-N
D-Î±-tocopherylacetate
Chemical compound


CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C
ZAKOWWREFLAJOT-CEFNRUSXSA-N
0.000
description
10


229940042585
Tocopherol Acetate
Drugs




0.000
description
10


229960001452
alpha-Tocopherol Acetate
Drugs




0.000
description
10


239000002537
cosmetic
Substances




0.000
description
10


229940008099
dimethicone
Drugs




0.000
description
10


239000004205
dimethyl polysiloxane
Substances




0.000
description
10


238000009472
formulation
Methods




0.000
description
10


239000000171
lavandula angustifolia l. flower oil
Substances




0.000
description
10


150000002632
lipids
Chemical class




0.000
description
10


239000002994
raw material
Substances




0.000
description
10


FWKQNCXZGNBPFD-UHFFFAOYSA-N
1,4-dimethyl-7-(1-methylethyl)azulene
Chemical compound


CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1
FWKQNCXZGNBPFD-UHFFFAOYSA-N
0.000
description
8


AXISYYRBXTVTFY-UHFFFAOYSA-N
Isopropyl myristate
Chemical compound


CCCCCCCCCCCCCC(=O)OC(C)C
AXISYYRBXTVTFY-UHFFFAOYSA-N
0.000
description
8


VAMXMNNIEUEQDV-UHFFFAOYSA-N
Methyl anthranilate
Chemical compound


COC(=O)C1=CC=CC=C1N
VAMXMNNIEUEQDV-UHFFFAOYSA-N
0.000
description
8


YBGZDTIWKVFICR-JLHYYAGUSA-N
Octyl methoxycinnamate
Chemical compound


CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1
YBGZDTIWKVFICR-JLHYYAGUSA-N
0.000
description
8


235000019502
Orange oil
Nutrition




0.000
description
8


240000005809
Prunus persica
Species




0.000
description
8


YGSDEFSMJLZEOE-UHFFFAOYSA-N
Salicylic acid
Chemical compound


OC(=O)C1=CC=CC=C1O
YGSDEFSMJLZEOE-UHFFFAOYSA-N
0.000
description
8


PRAKJMSDJKAYCZ-UHFFFAOYSA-N
Squalane
Chemical compound


CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C
PRAKJMSDJKAYCZ-UHFFFAOYSA-N
0.000
description
8


YYGNTYWPHWGJRM-RUSDCZJESA-N
Squalene
Natural products


C(=C\CC/C(=C\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\C)/C)/C
YYGNTYWPHWGJRM-RUSDCZJESA-N
0.000
description
8


235000013832
Valeriana officinalis
Nutrition




0.000
description
8


240000006745
Valeriana officinalis
Species




0.000
description
8


239000004359
castor oil
Substances




0.000
description
8


235000019438
castor oil
Nutrition




0.000
description
8


GXGJIOMUZAGVEH-UHFFFAOYSA-N
charmazulen
Natural products


CCC1=CC=C(C)C2=CC=C(C)C2=C1
GXGJIOMUZAGVEH-UHFFFAOYSA-N
0.000
description
8


239000001279
citrus aurantifolia swingle expressed oil
Substances




0.000
description
8


229940074928
isopropyl myristate
Drugs




0.000
description
8


229960001238
methylnicotinate
Drugs




0.000
description
8


229960001679
octinoxate
Drugs




0.000
description
8


239000010502
orange oil
Substances




0.000
description
8


DNIAPMSPPWPWGF-UHFFFAOYSA-N
propylene glycol
Chemical compound


CC(O)CO
DNIAPMSPPWPWGF-UHFFFAOYSA-N
0.000
description
8


150000004670
unsaturated fatty acids
Chemical class




0.000
description
8


235000021122
unsaturated fatty acids
Nutrition




0.000
description
8


235000016788
valerian
Nutrition




0.000
description
8


XLYOFNOQVPJJNP-UHFFFAOYSA-N
water
Substances


O
XLYOFNOQVPJJNP-UHFFFAOYSA-N
0.000
description
8


NOOLISFMXDJSKH-UTLUCORTSA-N
(+)-Neomenthol
Chemical compound


CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O
NOOLISFMXDJSKH-UTLUCORTSA-N
0.000
description
6


CUNWUEBNSZSNRX-RKGWDQTMSA-N
(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid
Chemical compound


OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O
CUNWUEBNSZSNRX-RKGWDQTMSA-N
0.000
description
6


LVYLCBNXHHHPSB-UHFFFAOYSA-N
2-hydroxyethyl salicylate
Chemical compound


OCCOC(=O)C1=CC=CC=C1O
LVYLCBNXHHHPSB-UHFFFAOYSA-N
0.000
description
6


LEACJMVNYZDSKR-UHFFFAOYSA-N
2-octyldodecan-1-ol
Chemical compound


CCCCCCCCCCC(CO)CCCCCCCC
LEACJMVNYZDSKR-UHFFFAOYSA-N
0.000
description
6


229940063655
Aluminum stearate
Drugs




0.000
description
6


BXWNKGSJHAJOGX-UHFFFAOYSA-N
Cetyl alcohol
Chemical compound


CCCCCCCCCCCCCCCCO
BXWNKGSJHAJOGX-UHFFFAOYSA-N
0.000
description
6


UQEAIHBTYFGYIE-UHFFFAOYSA-N
Hexamethyldisiloxane
Chemical compound


C[Si](C)(C)O[Si](C)(C)C
UQEAIHBTYFGYIE-UHFFFAOYSA-N
0.000
description
6


229960004881
Homosalate
Drugs




0.000
description
6


229960004873
LEVOMENTHOL
Drugs




0.000
description
6


229940041616
Menthol
Drugs




0.000
description
6


ALSTYHKOOCGGFT-KTKRTIGZSA-N
Oleyl alcohol
Chemical compound


CCCCCCCC\C=C/CCCCCCCCO
ALSTYHKOOCGGFT-KTKRTIGZSA-N
0.000
description
6


239000004698
Polyethylene (PE)
Substances




0.000
description
6


229920001451
Polypropylene glycol
Polymers




0.000
description
6


229960005078
Sorbitan sesquioleate
Drugs




0.000
description
6


CEGOLXSVJUTHNZ-UHFFFAOYSA-K
aluminium tristearate
Chemical compound


[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O
CEGOLXSVJUTHNZ-UHFFFAOYSA-K
0.000
description
6


WVDDGKGOMKODPV-UHFFFAOYSA-N
benzyl alcohol
Chemical compound


OCC1=CC=CC=C1
WVDDGKGOMKODPV-UHFFFAOYSA-N
0.000
description
6


229920001577
copolymer
Polymers




0.000
description
6


239000001941
cymbopogon citratus dc and cymbopogon flexuosus oil
Substances




0.000
description
6


239000001939
cymbopogon martini roxb. stapf. oil
Substances




0.000
description
6


SASYSVUEVMOWPL-NXVVXOECSA-N
decyl oleate
Chemical compound


CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC
SASYSVUEVMOWPL-NXVVXOECSA-N
0.000
description
6


239000000839
emulsion
Substances




0.000
description
6


229960002389
glycol salicylate
Drugs




0.000
description
6


239000000787
lecithin
Substances




0.000
description
6


235000010445
lecithin
Nutrition




0.000
description
6


239000002502
liposome
Substances




0.000
description
6


229920001983
poloxamer
Polymers




0.000
description
6


239000008389
polyethoxylated castor oil
Substances




0.000
description
6


229920000036
polyvinylpyrrolidone
Polymers




0.000
description
6


235000013855
polyvinylpyrrolidone
Nutrition




0.000
description
6


239000004094
surface-active agent
Substances




0.000
description
6


BODMYPYTCKYRSP-UHFFFAOYSA-N
1,1-dioctylcyclohexane
Chemical compound


CCCCCCCCC1(CCCCCCCC)CCCCC1
BODMYPYTCKYRSP-UHFFFAOYSA-N
0.000
description
4


OWEGWHBOCFMBLP-UHFFFAOYSA-N
1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one
Chemical compound


C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1
OWEGWHBOCFMBLP-UHFFFAOYSA-N
0.000
description
4


JLPULHDHAOZNQI-ZTIMHPMXSA-N
1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine
Chemical compound


CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC
JLPULHDHAOZNQI-ZTIMHPMXSA-N
0.000
description
4


NKJOXAZJBOMXID-UHFFFAOYSA-N
1-octoxyoctane
Chemical compound


CCCCCCCCOCCCCCCCC
NKJOXAZJBOMXID-UHFFFAOYSA-N
0.000
description
4


XDOFQFKRPWOURC-UHFFFAOYSA-M
16-methylheptadecanoate
Chemical compound


CC(C)CCCCCCCCCCCCCCC([O-])=O
XDOFQFKRPWOURC-UHFFFAOYSA-M
0.000
description
4


MPDGHEJMBKOTSU-YKLVYJNSSA-N
18Î²-glycyrrhetic acid
Chemical compound


C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C
MPDGHEJMBKOTSU-YKLVYJNSSA-N
0.000
description
4


PHDVPEOLXYBNJY-KTKRTIGZSA-N
2-(2-hydroxyethoxy)ethyl (Z)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCO
PHDVPEOLXYBNJY-KTKRTIGZSA-N
0.000
description
4


IMQYZLJIDNYQLX-UHFFFAOYSA-M
2-hydroxy-4-octadecoxy-2-(2-octadecoxy-2-oxoethyl)-4-oxobutanoate
Chemical compound


CCCCCCCCCCCCCCCCCCOC(=O)CC(O)(C([O-])=O)CC(=O)OCCCCCCCCCCCCCCCCCC
IMQYZLJIDNYQLX-UHFFFAOYSA-M
0.000
description
4


BANXPJUEBPWEOT-UHFFFAOYSA-N
2-methylpentadecane
Chemical compound


CCCCCCCCCCCCCC(C)C
BANXPJUEBPWEOT-UHFFFAOYSA-N
0.000
description
4


HEOCBCNFKCOKBX-SDNWHVSQSA-N
4-Methylbenzylidene camphor
Chemical compound


C1=CC(C)=CC=C1\C=C/1C(=O)C2(C)CCC\1C2(C)C
HEOCBCNFKCOKBX-SDNWHVSQSA-N
0.000
description
4


POJWUDADGALRAB-PVQJCKRUSA-N
Allantoin
Natural products


NC(=O)N[C@@H]1NC(=O)NC1=O
POJWUDADGALRAB-PVQJCKRUSA-N
0.000
description
4


WPYMKLBDIGXBTP-UHFFFAOYSA-N
Benzoic acid
Chemical compound


OC(=O)C1=CC=CC=C1
WPYMKLBDIGXBTP-UHFFFAOYSA-N
0.000
description
4


229960002747
Betacarotene
Drugs




0.000
description
4


240000001432
Calendula officinalis
Species




0.000
description
4


DSSYKIVIOFKYAU-UHFFFAOYSA-N
Camphor
Chemical compound


C1CC2(C)C(=O)CC1C2(C)C
DSSYKIVIOFKYAU-UHFFFAOYSA-N
0.000
description
4


229960000846
Camphor
Drugs




0.000
description
4


240000007436
Cananga odorata
Species




0.000
description
4


241000723346
Cinnamomum camphora
Species




0.000
description
4


KRKNYBCHXYNGOX-UHFFFAOYSA-N
Citric acid
Natural products


OC(=O)CC(O)(C(O)=O)CC(O)=O
KRKNYBCHXYNGOX-UHFFFAOYSA-N
0.000
description
4


235000008733
Citrus aurantifolia
Nutrition




0.000
description
4


229960003344
Climbazole
Drugs




0.000
description
4


XTJFFFGAUHQWII-UHFFFAOYSA-N
Dibutyl adipate
Chemical compound


CCCCOC(=O)CCCCC(=O)OCCCC
XTJFFFGAUHQWII-UHFFFAOYSA-N
0.000
description
4


229940044949
Eucalyptus oil
Drugs




0.000
description
4


240000008669
Hedera helix
Species




0.000
description
4


241000721662
Juniperus
Species




0.000
description
4


229940067606
Lecithin
Drugs




0.000
description
4


OYHQOLUKZRVURQ-IXWMQOLASA-N
Linoleic acid
Natural products


CCCCC\C=C/C\C=C\CCCCCCCC(O)=O
OYHQOLUKZRVURQ-IXWMQOLASA-N
0.000
description
4


235000016247
Mentha requienii
Nutrition




0.000
description
4


235000002899
Mentha suaveolens
Nutrition




0.000
description
4


OSWPMRLSEDHDFF-UHFFFAOYSA-N
Methyl salicylate
Chemical compound


COC(=O)C1=CC=CC=C1O
OSWPMRLSEDHDFF-UHFFFAOYSA-N
0.000
description
4


FMJSMJQBSVNSBF-UHFFFAOYSA-N
Octocrylene
Chemical group


C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1
FMJSMJQBSVNSBF-UHFFFAOYSA-N
0.000
description
4


229940049964
Oleate
Drugs




0.000
description
4


DXGLGDHPHMLXJC-UHFFFAOYSA-N
Oxybenzone
Chemical compound


OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1
DXGLGDHPHMLXJC-UHFFFAOYSA-N
0.000
description
4


229940048845
POLYGLYCERYL-3 DIISOSTEARATE
Drugs




0.000
description
4


WYWZRNAHINYAEF-UHFFFAOYSA-N
Padimate O
Chemical compound


CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1
WYWZRNAHINYAEF-UHFFFAOYSA-N
0.000
description
4


239000004721
Polyphenylene oxide
Substances




0.000
description
4


241000048284
Potato virus P
Species




0.000
description
4


229960004063
Propylene glycol
Drugs




0.000
description
4


241001530490
Salvia rosmarinus
Species




0.000
description
4


229940075582
Sorbic Acid
Drugs




0.000
description
4


229940031439
Squalene
Drugs




0.000
description
4


235000015450
Tilia cordata
Nutrition




0.000
description
4


235000011941
Tilia x europaea
Nutrition




0.000
description
4


238000010521
absorption reaction
Methods




0.000
description
4


235000014104
aloe vera supplement
Nutrition




0.000
description
4


239000002260
anti-inflammatory agent
Substances




0.000
description
4


125000003289
ascorbyl group
Chemical group


[H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O*

0.000
description
4


150000001545
azulenes
Chemical class




0.000
description
4


OENHQHLEOONYIE-VYAWBVGESA-N
beta-Carotene
Natural products


CC=1CCCC(C)(C)C=1\C=C\C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C
OENHQHLEOONYIE-VYAWBVGESA-N
0.000
description
4


239000011648
beta-carotene
Substances




0.000
description
4


235000013734
beta-carotene
Nutrition




0.000
description
4


235000006682
bigleaf mint
Nutrition




0.000
description
4


230000015572
biosynthetic process
Effects




0.000
description
4


229930007890
camphor
Natural products




0.000
description
4


238000001035
drying
Methods




0.000
description
4


229960004697
enzacamene
Drugs




0.000
description
4


239000010642
eucalyptus oil
Substances




0.000
description
4


150000004665
fatty acids
Chemical class




0.000
description
4


239000012530
fluid
Substances




0.000
description
4


238000005755
formation reaction
Methods




0.000
description
4


239000003205
fragrance
Substances




0.000
description
4


229960002350
guaiazulen
Drugs




0.000
description
4


229940057502
guaiazulene
Drugs




0.000
description
4


IIRDTKBZINWQAW-UHFFFAOYSA-N
hexaethylene glycol
Chemical compound


OCCOCCOCCOCCOCCOCCO
IIRDTKBZINWQAW-UHFFFAOYSA-N
0.000
description
4


KFZMGEQAYNKOFK-UHFFFAOYSA-N
iso-propanol
Chemical compound


CC(C)O
KFZMGEQAYNKOFK-UHFFFAOYSA-N
0.000
description
4


239000004571
lime
Substances




0.000
description
4


229940102398
methyl anthranilate
Drugs




0.000
description
4


235000006679
mint
Nutrition




0.000
description
4


235000019720
niaouli oil
Nutrition




0.000
description
4


239000007764
o/w emulsion
Substances




0.000
description
4


229960000601
octocrylene
Drugs




0.000
description
4


ZQPPMHVWECSIRJ-KTKRTIGZSA-M
oleate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC([O-])=O
ZQPPMHVWECSIRJ-KTKRTIGZSA-M
0.000
description
4


229940055577
oleyl alcohol
Drugs




0.000
description
4


239000004006
olive oil
Substances




0.000
description
4


235000008390
olive oil
Nutrition




0.000
description
4


229960001173
oxybenzone
Drugs




0.000
description
4


IPCSVZSSVZVIGE-UHFFFAOYSA-M
palmitate
Chemical compound


CCCCCCCCCCCCCCCC([O-])=O
IPCSVZSSVZVIGE-UHFFFAOYSA-M
0.000
description
4


125000000913
palmityl group
Chemical group


[H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]

0.000
description
4


229920000570
polyether
Polymers




0.000
description
4


239000001944
prunus armeniaca kernel oil
Substances




0.000
description
4


239000005871
repellent
Substances




0.000
description
4


229960004889
salicylic acid
Drugs




0.000
description
4


239000007787
solid
Substances




0.000
description
4


235000010199
sorbic acid
Nutrition




0.000
description
4


239000004334
sorbic acid
Substances




0.000
description
4


WSWCOQWTEOXDQX-UHFFFAOYSA-N
sorbic acid
Chemical compound


CC=CC=CC(O)=O
WSWCOQWTEOXDQX-UHFFFAOYSA-N
0.000
description
4


VYGQUTWHTHXGQB-FFHKNEKCSA-N
trans-Retinyl palmitate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
VYGQUTWHTHXGQB-FFHKNEKCSA-N
0.000
description
4


238000005406
washing
Methods




0.000
description
4


DTOSIQBPPRVQHS-PDBXOOCHSA-N
Î±-linolenic acid
Chemical compound


CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
DTOSIQBPPRVQHS-PDBXOOCHSA-N
0.000
description
4


OENHQHLEOONYIE-JLTXGRSLSA-N
Î²-Carotene
Chemical compound


CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
OENHQHLEOONYIE-JLTXGRSLSA-N
0.000
description
4


WJNMPINWDAQWSW-UNTBIKODSA-N
(12R)-12-hydroxyoctadec-9-enoic acid;propane-1,2-diol
Chemical compound


CC(O)CO.CCCCCC[C@@H](O)CC=CCCCCCCCC(O)=O
WJNMPINWDAQWSW-UNTBIKODSA-N
0.000
description
2


UVBQLWCHVJXJJX-UHFFFAOYSA-N
(2-methyl-1-phenylpropyl) 2-hydroxybenzoate
Chemical class


C=1C=CC=CC=1C(C(C)C)OC(=O)C1=CC=CC=C1O
UVBQLWCHVJXJJX-UHFFFAOYSA-N
0.000
description
2


KSEBMYQBYZTDHS-HWKANZROSA-M
(E)-Ferulic acid
Natural products


COC1=CC(\C=C\C([O-])=O)=CC=C1O
KSEBMYQBYZTDHS-HWKANZROSA-M
0.000
description
2


OVYMWJFNQQOJBU-UHFFFAOYSA-N
1-octanoyloxypropan-2-yl octanoate
Chemical compound


CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC
OVYMWJFNQQOJBU-UHFFFAOYSA-N
0.000
description
2


RZRNAYUHWVFMIP-KTKRTIGZSA-N
1-oleoylglycerol
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO
RZRNAYUHWVFMIP-KTKRTIGZSA-N
0.000
description
2


229940043268
2,2,4,4,6,8,8-heptamethylnonane
Drugs




0.000
description
2


NRANXTWANPHZAU-UHFFFAOYSA-N
2-(1H-quinolin-2-ylidene)indene-1,3-dione
Chemical compound


N1C2=CC=CC=C2C=CC1=C1C(=O)C2=CC=CC=C2C1=O
NRANXTWANPHZAU-UHFFFAOYSA-N
0.000
description
2


PWVUXRBUUYZMKM-UHFFFAOYSA-N
2-(2-hydroxyethoxy)ethyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCOCCO
PWVUXRBUUYZMKM-UHFFFAOYSA-N
0.000
description
2


KUXGUCNZFCVULO-UHFFFAOYSA-N
2-(4-nonylphenoxy)ethanol
Chemical compound


CCCCCCCCCC1=CC=C(OCCO)C=C1
KUXGUCNZFCVULO-UHFFFAOYSA-N
0.000
description
2


MQFYRUGXOJAUQK-UHFFFAOYSA-N
2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC
MQFYRUGXOJAUQK-UHFFFAOYSA-N
0.000
description
2


TYYHDKOVFSVWON-UHFFFAOYSA-N
2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione
Chemical compound


C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1
TYYHDKOVFSVWON-UHFFFAOYSA-N
0.000
description
2


ZVUNTIMPQCQCAQ-UHFFFAOYSA-N
2-dodecanoyloxyethyl dodecanoate
Chemical compound


CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC
ZVUNTIMPQCQCAQ-UHFFFAOYSA-N
0.000
description
2


MUHFRORXWCGZGE-KTKRTIGZSA-N
2-hydroxyethyl (Z)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OCCO
MUHFRORXWCGZGE-KTKRTIGZSA-N
0.000
description
2


XLMXUUQMSMKFMH-UZRURVBFSA-N
2-hydroxyethyl (Z,12R)-12-hydroxyoctadec-9-enoate
Chemical compound


CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCCO
XLMXUUQMSMKFMH-UZRURVBFSA-N
0.000
description
2


XPJVKCRENWUEJH-UHFFFAOYSA-N
2-methylpropyl 4-hydroxybenzoate
Chemical compound


CC(C)COC(=O)C1=CC=C(O)C=C1
XPJVKCRENWUEJH-UHFFFAOYSA-N
0.000
description
2


SGRCVQDBWHCTIS-UHFFFAOYSA-N
2-nonanoyloxypropyl nonanoate
Chemical compound


CCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCC
SGRCVQDBWHCTIS-UHFFFAOYSA-N
0.000
description
2


KRKNYBCHXYNGOX-UHFFFAOYSA-K
2qpq
Chemical compound


[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O
KRKNYBCHXYNGOX-UHFFFAOYSA-K
0.000
description
2


RMTFNDVZYPHUEF-XZBKPIIZSA-N
3-O-methyl-D-glucose
Chemical compound


O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO
RMTFNDVZYPHUEF-XZBKPIIZSA-N
0.000
description
2


PGRHXDWITVMQBC-UHFFFAOYSA-N
3-acetyl-6-methylpyran-2,4-dione
Chemical compound


CC(=O)C1C(=O)OC(C)=CC1=O
PGRHXDWITVMQBC-UHFFFAOYSA-N
0.000
description
2


229940099451
3-iodo-2-propynylbutylcarbamate
Drugs




0.000
description
2


ALYNCZNDIQEVRV-UHFFFAOYSA-N
4-Aminobenzoic acid
Chemical compound


NC1=CC=C(C(O)=O)C=C1
ALYNCZNDIQEVRV-UHFFFAOYSA-N
0.000
description
2


229910002012
AerosilÂ®
Inorganic materials




0.000
description
2


229960000458
Allantoin
Drugs




0.000
description
2


235000019489
Almond oil
Nutrition




0.000
description
2


WNROFYMDJYEPJX-UHFFFAOYSA-K
Aluminium hydroxide
Chemical compound


[OH-].[OH-].[OH-].[Al+3]
WNROFYMDJYEPJX-UHFFFAOYSA-K
0.000
description
2


UBNYRXMKIIGMKK-RMKNXTFCSA-N
Amiloxate
Chemical compound


COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1
UBNYRXMKIIGMKK-RMKNXTFCSA-N
0.000
description
2


241000086254
Arnica montana
Species




0.000
description
2


VLPFTAMPNXLGLX-UHFFFAOYSA-N
Axona
Chemical compound


CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC
VLPFTAMPNXLGLX-UHFFFAOYSA-N
0.000
description
2


239000005711
Benzoic acid
Substances




0.000
description
2


RGZSQWQPBWRIAQ-CABCVRRESA-N
Bisabolol
Chemical compound


CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1
RGZSQWQPBWRIAQ-CABCVRRESA-N
0.000
description
2


235000003880
Calendula
Nutrition




0.000
description
2


235000005881
Calendula officinalis
Nutrition




0.000
description
2


BVKZGUZCCUSVTD-UHFFFAOYSA-L
Carbonate dianion
Chemical compound


[O-]C([O-])=O
BVKZGUZCCUSVTD-UHFFFAOYSA-L
0.000
description
2


ACTIUHUUMQJHFO-UPTCCGCDSA-N
Coenzyme Q10
Chemical compound


COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O
ACTIUHUUMQJHFO-UPTCCGCDSA-N
0.000
description
2


241000195493
Cryptophyta
Species




0.000
description
2


WQZGKKKJIJFFOK-GASJEMHNSA-N
D-Glucose
Natural products


OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O
WQZGKKKJIJFFOK-GASJEMHNSA-N
0.000
description
2


MMOXZBCLCQITDF-UHFFFAOYSA-N
DEET
Chemical compound


CCN(CC)C(=O)C1=CC=CC(C)=C1
MMOXZBCLCQITDF-UHFFFAOYSA-N
0.000
description
2


NIQCNGHVCWTJSM-UHFFFAOYSA-N
Dimethyl phthalate
Chemical compound


COC(=O)C1=CC=CC=C1C(=O)OC
NIQCNGHVCWTJSM-UHFFFAOYSA-N
0.000
description
2


RPWFJAMTCNSJKK-UHFFFAOYSA-N
Dodecyl gallate
Chemical group


CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1
RPWFJAMTCNSJKK-UHFFFAOYSA-N
0.000
description
2


GHXZTYHSJHQHIJ-UHFFFAOYSA-N
Exidine
Chemical class


C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1
GHXZTYHSJHQHIJ-UHFFFAOYSA-N
0.000
description
2


KSEBMYQBYZTDHS-HWKANZROSA-N
Ferulic acid
Chemical compound


COC1=CC(\C=C\C(O)=O)=CC=C1O
KSEBMYQBYZTDHS-HWKANZROSA-N
0.000
description
2


229940074046
GLYCERYL LAURATE
Drugs




0.000
description
2


229940085633
GLYCERYL LINOLENATE
Drugs




0.000
description
2


229940116338
GLYCERYL RICINOLEATE
Drugs




0.000
description
2


229940002508
Ginger extract
Drugs




0.000
description
2


210000004907
Glands
Anatomy




0.000
description
2


229940073144
Glycyrrhetinic acid
Drugs




0.000
description
2


229940057871
HYDROGENATED PALM GLYCERIDES
Drugs




0.000
description
2


241000258937
Hemiptera
Species




0.000
description
2


229940090854
Hexyldecyl Laurate
Drugs




0.000
description
2


241000546188
Hypericum
Species




0.000
description
2


229940093629
ISOPROPYL ISOSTEARATE
Drugs




0.000
description
2


WYVVKGNFXHOCQV-UHFFFAOYSA-N
Iodopropynyl butylcarbamate
Chemical compound


CCCCNC(=O)OCC#CI
WYVVKGNFXHOCQV-UHFFFAOYSA-N
0.000
description
2


240000000661
Kaempferia galanga
Species




0.000
description
2


235000013421
Kaempferia galanga
Nutrition




0.000
description
2


241001484259
Lacuna
Species




0.000
description
2


229960004488
Linolenic Acid
Drugs




0.000
description
2


229940044591
METHYL GLUCOSE DIOLEATE
Drugs




0.000
description
2


VTHJTEIRLNZDEV-UHFFFAOYSA-L
Magnesium hydroxide
Chemical compound


[OH-].[OH-].[Mg+2]
VTHJTEIRLNZDEV-UHFFFAOYSA-L
0.000
description
2


ARIWANIATODDMH-UHFFFAOYSA-N
Monolaurin
Chemical compound


CCCCCCCCCCCC(=O)OCC(O)CO
ARIWANIATODDMH-UHFFFAOYSA-N
0.000
description
2


229940105132
Myristate
Drugs




0.000
description
2


229940120511
OLEYL ERUCATE
Drugs




0.000
description
2


229960003921
Octisalate
Drugs




0.000
description
2


229940031709
PEG-30-dipolyhydroxystearate
Drugs




0.000
description
2


229940086539
PEG-7 GLYCERYL COCOATE
Drugs




0.000
description
2


GHOKWGTUZJEAQD-UHFFFAOYSA-N
Pantothenic acid
Chemical class


OCC(C)(C)C(O)C(=O)NCCC(O)=O
GHOKWGTUZJEAQD-UHFFFAOYSA-N
0.000
description
2


SJEYSFABYSGQBG-UHFFFAOYSA-M
Patent blue
Chemical compound


[Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1
SJEYSFABYSGQBG-UHFFFAOYSA-M
0.000
description
2


235000019483
Peanut oil
Nutrition




0.000
description
2


QCDWFXQBSFUVSP-UHFFFAOYSA-N
Phenoxyethanol
Chemical compound


OCCOC1=CC=CC=C1
QCDWFXQBSFUVSP-UHFFFAOYSA-N
0.000
description
2


229960005323
Phenoxyethanol
Drugs




0.000
description
2


241000218657
Picea
Species




0.000
description
2


235000008331
Pinus X rigitaeda
Nutrition




0.000
description
2


235000011613
Pinus brutia
Nutrition




0.000
description
2


241000018646
Pinus brutia
Species




0.000
description
2


BTSZTGGZJQFALU-UHFFFAOYSA-N
Piroctone olamine
Chemical compound


NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O
BTSZTGGZJQFALU-UHFFFAOYSA-N
0.000
description
2


229920003171
Poly (ethylene oxide)
Polymers




0.000
description
2


239000002202
Polyethylene glycol
Substances




0.000
description
2


RUOJZAUFBMNUDX-UHFFFAOYSA-N
Propylene carbonate
Chemical compound


CC1COC(=O)O1
RUOJZAUFBMNUDX-UHFFFAOYSA-N
0.000
description
2


229940081967
Rutin
Drugs




0.000
description
2


229940057429
SORBITAN ISOSTEARATE
Drugs




0.000
description
2


206010039792
Seborrhoea
Diseases




0.000
description
2


NWGKJDSIEKMTRX-MDZDMXLPSA-N
Sorbitan oleate
Chemical compound


CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O
NWGKJDSIEKMTRX-MDZDMXLPSA-N
0.000
description
2


229950004959
Sorbitan oleate
Drugs




0.000
description
2


229950011392
Sorbitan stearate
Drugs




0.000
description
2


229960000391
Sorbitan trioleate
Drugs




0.000
description
2


IJCWFDPJFXGQBN-BIFNRIDTSA-N
Sorbitan tristearate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@@H](O)[C@@H]1OC(=O)CCCCCCCCCCCCCCCCC
IJCWFDPJFXGQBN-BIFNRIDTSA-N
0.000
description
2


235000002197
St. Johnâs wort
Nutrition




0.000
description
2


229940102548
Stearalkonium Hectorite
Drugs




0.000
description
2


IVHQFXJEJHVLIW-UHFFFAOYSA-L
Stearalkonium hectorite
Chemical compound


[Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2.CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1
IVHQFXJEJHVLIW-UHFFFAOYSA-L
0.000
description
2


235000012311
Tagetes erecta
Nutrition




0.000
description
2


235000003595
Tagetes minuta
Nutrition




0.000
description
2


MSCCTZZBYHQMQJ-AZAGJHQNSA-N
Tocopheryl nicotinate
Chemical compound


C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1
MSCCTZZBYHQMQJ-AZAGJHQNSA-N
0.000
description
2


XEFQLINVKFYRCS-UHFFFAOYSA-N
Triclosan
Chemical compound


OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl
XEFQLINVKFYRCS-UHFFFAOYSA-N
0.000
description
2


239000004164
Wax ester
Substances




0.000
description
2


FGUZFFWTBWJBIL-XWVZOOPGSA-N
[(1R)-1-[(2S,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate
Chemical compound


CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O
FGUZFFWTBWJBIL-XWVZOOPGSA-N
0.000
description
2


NWGKJDSIEKMTRX-HSACVWGTSA-N
[(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (E)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O
NWGKJDSIEKMTRX-HSACVWGTSA-N
0.000
description
2


NWGKJDSIEKMTRX-BFWOXRRGSA-N
[(2R)-2-[(3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (Z)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O
NWGKJDSIEKMTRX-BFWOXRRGSA-N
0.000
description
2


SZAMSYKZCSDVBH-CLFAGFIQSA-N
[(Z)-octadec-9-enyl] (Z)-docos-13-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC
SZAMSYKZCSDVBH-CLFAGFIQSA-N
0.000
description
2


HVUMOYIDDBPOLL-IIZJTUPISA-N
[2-[(2R,3S,4R)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@@H](O)[C@@H]1O
HVUMOYIDDBPOLL-IIZJTUPISA-N
0.000
description
2


PRXRUNOAOLTIEF-XDTJCZEISA-N
[2-[(2R,3S,4R)-4-hydroxy-3-[(Z)-octadec-9-enoyl]oxyoxolan-2-yl]-2-[(Z)-octadec-9-enoyl]oxyethyl] (Z)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@@H](O)[C@@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC
PRXRUNOAOLTIEF-XDTJCZEISA-N
0.000
description
2


DRAWQKGUORNASA-YAFCTCPESA-N
[2-hydroxy-3-[(E)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC\C=C/CCCCCCCC
DRAWQKGUORNASA-YAFCTCPESA-N
0.000
description
2


ZJLATTXAOOPYRU-UHFFFAOYSA-N
[3-hydroxy-2,2-bis(hydroxymethyl)propyl] dodecanoate
Chemical compound


CCCCCCCCCCCC(=O)OCC(CO)(CO)CO
ZJLATTXAOOPYRU-UHFFFAOYSA-N
0.000
description
2


LKTOWUZQHJSGAK-UHFFFAOYSA-M
[O-]C1=CC=CC=C1.C1CC2(C)C(=O)CC1C2(C)C
Chemical compound


[O-]C1=CC=CC=C1.C1CC2(C)C(=O)CC1C2(C)C
LKTOWUZQHJSGAK-UHFFFAOYSA-M
0.000
description
2


239000002253
acid
Substances




0.000
description
2


150000007513
acids
Chemical class




0.000
description
2


238000007792
addition
Methods




0.000
description
2


125000005907
alkyl ester group
Chemical group




0.000
description
2


ANVAOWXLWRTKGA-XHGAXZNDSA-N
all-trans-Î±-carotene
Chemical compound


CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C
ANVAOWXLWRTKGA-XHGAXZNDSA-N
0.000
description
2


239000008168
almond oil
Substances




0.000
description
2


150000001280
alpha hydroxy acids
Chemical class




0.000
description
2


ANVAOWXLWRTKGA-HLLMEWEMSA-N
alpha-Carotene
Natural products


C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C
ANVAOWXLWRTKGA-HLLMEWEMSA-N
0.000
description
2


235000003903
alpha-carotene
Nutrition




0.000
description
2


239000011795
alpha-carotene
Substances




0.000
description
2


235000020661
alpha-linolenic acid
Nutrition




0.000
description
2


229910052782
aluminium
Inorganic materials




0.000
description
2


XAGFODPZIPBFFR-UHFFFAOYSA-N
aluminum
Chemical compound


[Al]
XAGFODPZIPBFFR-UHFFFAOYSA-N
0.000
description
2


230000003078
antioxidant
Effects




0.000
description
2


238000000222
aromatherapy
Methods




0.000
description
2


229960005193
avobenzone
Drugs




0.000
description
2


235000021302
avocado oil
Nutrition




0.000
description
2


239000008163
avocado oil
Substances




0.000
description
2


235000010233
benzoic acid
Nutrition




0.000
description
2


235000019445
benzyl alcohol
Nutrition




0.000
description
2


150000001277
beta hydroxy acids
Chemical class




0.000
description
2


229940036350
bisabolol
Drugs




0.000
description
2


229930000006
bisabolols
Natural products




0.000
description
2


239000010627
cedar oil
Substances




0.000
description
2


239000007765
cera alba
Substances




0.000
description
2


229940081620
ceteth-2
Drugs




0.000
description
2


229960000541
cetyl alcohol
Drugs




0.000
description
2


235000019804
chlorophyll
Nutrition




0.000
description
2


ATNHDLDRLWWWCB-AENOIHSZSA-M
chlorophyll a
Chemical compound


C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5
ATNHDLDRLWWWCB-AENOIHSZSA-M
0.000
description
2


229930002875
chlorophylls
Natural products




0.000
description
2


239000010630
cinnamon oil
Substances




0.000
description
2


239000010634
clove oil
Substances




0.000
description
2


238000001816
cooling
Methods




0.000
description
2


230000000875
corresponding
Effects




0.000
description
2


239000006071
cream
Substances




0.000
description
2


229940086555
cyclomethicone
Drugs




0.000
description
2


239000010639
cypress oil
Substances




0.000
description
2


229940100539
dibutyl adipate
Drugs




0.000
description
2


229960001826
dimethylphthalate
Drugs




0.000
description
2


KARVSHNNUWMXFO-UHFFFAOYSA-N
dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate
Chemical class


O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O
KARVSHNNUWMXFO-UHFFFAOYSA-N
0.000
description
2


LLRANSBEYQZKFY-UHFFFAOYSA-N
dodecanoic acid;propane-1,2-diol
Chemical compound


CC(O)CO.CCCCCCCCCCCC(O)=O
LLRANSBEYQZKFY-UHFFFAOYSA-N
0.000
description
2


DLAHAXOYRFRPFQ-UHFFFAOYSA-N
dodecyl benzoate
Chemical compound


CCCCCCCCCCCCOC(=O)C1=CC=CC=C1
DLAHAXOYRFRPFQ-UHFFFAOYSA-N
0.000
description
2


239000003814
drug
Substances




0.000
description
2


229940079593
drugs
Drugs




0.000
description
2


235000020694
echinacea extract
Nutrition




0.000
description
2


229910001651
emery
Inorganic materials




0.000
description
2


229960003720
enoxolone
Drugs




0.000
description
2


150000002194
fatty esters
Chemical class




0.000
description
2


229940114124
ferulic acid
Drugs




0.000
description
2


235000001785
ferulic acid
Nutrition




0.000
description
2


150000002215
flavonoids
Chemical class




0.000
description
2


229930003935
flavonoids
Natural products




0.000
description
2


235000017173
flavonoids
Nutrition




0.000
description
2


239000000499
gel
Substances




0.000
description
2


239000010648
geranium oil
Substances




0.000
description
2


235000019717
geranium oil
Nutrition




0.000
description
2


235000020708
ginger extract
Nutrition




0.000
description
2


239000008103
glucose
Substances




0.000
description
2


150000002314
glycerols
Chemical class




0.000
description
2


229940095098
glycol oleate
Drugs




0.000
description
2


229960004949
glycyrrhizic acid
Drugs




0.000
description
2


235000019410
glycyrrhizin
Nutrition




0.000
description
2


LPLVUJXQOOQHMX-QWBHMCJMSA-N
glycyrrhizinic acid
Chemical compound


O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O
LPLVUJXQOOQHMX-QWBHMCJMSA-N
0.000
description
2


239000010651
grapefruit oil
Substances




0.000
description
2


239000008169
grapeseed oil
Substances




0.000
description
2


230000003806
hair structure
Effects




0.000
description
2


238000010438
heat treatment
Methods




0.000
description
2


SFFVATKALSIZGN-UHFFFAOYSA-N
hexadecan-7-ol
Chemical compound


CCCCCCCCCC(O)CCCCCC
SFFVATKALSIZGN-UHFFFAOYSA-N
0.000
description
2


HERITQQEUQNOIP-UHFFFAOYSA-N
hexadecan-7-yl dodecanoate
Chemical compound


CCCCCCCCCCCC(=O)OC(CCCCCC)CCCCCCCCC
HERITQQEUQNOIP-UHFFFAOYSA-N
0.000
description
2


TYCUSKFOGZNIBO-UHFFFAOYSA-N
hexadecyl 3,4,5-trihydroxybenzoate
Chemical compound


CCCCCCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1
TYCUSKFOGZNIBO-UHFFFAOYSA-N
0.000
description
2


239000000017
hydrogel
Substances




0.000
description
2


230000002209
hydrophobic
Effects




0.000
description
2


POULHZVOKOAJMA-UHFFFAOYSA-M
laurate
Polymers


CCCCCCCCCCCC([O-])=O
POULHZVOKOAJMA-UHFFFAOYSA-M
0.000
description
2


229950004594
levomenol
Drugs




0.000
description
2


235000020778
linoleic acid
Nutrition




0.000
description
2


239000000314
lubricant
Substances




0.000
description
2


239000000347
magnesium hydroxide
Substances




0.000
description
2


229910001862
magnesium hydroxide
Inorganic materials




0.000
description
2


229960001047
methyl salicylate
Drugs




0.000
description
2


239000002480
mineral oil
Substances




0.000
description
2


238000002156
mixing
Methods




0.000
description
2


230000004048
modification
Effects




0.000
description
2


238000006011
modification reaction
Methods




0.000
description
2


TUNFSRHWOTWDNC-UHFFFAOYSA-M
myristate
Chemical compound


CCCCCCCCCCCCCC([O-])=O
TUNFSRHWOTWDNC-UHFFFAOYSA-M
0.000
description
2


230000001264
neutralization
Effects




0.000
description
2


PVNIIMVLHYAWGP-UHFFFAOYSA-N
nicotinic acid
Chemical class


OC(=O)C1=CC=CN=C1
PVNIIMVLHYAWGP-UHFFFAOYSA-N
0.000
description
2


WNIFXKPDILJURQ-JKPOUOEOSA-N
octadecyl (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate
Chemical compound


C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C
WNIFXKPDILJURQ-JKPOUOEOSA-N
0.000
description
2


WWZKQHOCKIZLMA-UHFFFAOYSA-M
octanoate
Chemical compound


CCCCCCCC([O-])=O
WWZKQHOCKIZLMA-UHFFFAOYSA-M
0.000
description
2


WCJLCOAEJIHPCW-UHFFFAOYSA-N
octyl 2-hydroxybenzoate
Chemical compound


CCCCCCCCOC(=O)C1=CC=CC=C1O
WCJLCOAEJIHPCW-UHFFFAOYSA-N
0.000
description
2


NRPKURNSADTHLJ-UHFFFAOYSA-N
octyl gallate
Chemical group


CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1
NRPKURNSADTHLJ-UHFFFAOYSA-N
0.000
description
2


125000002347
octyl group
Chemical group


[H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]

0.000
description
2


230000037312
oily skin
Effects




0.000
description
2


239000000312
peanut oil
Substances




0.000
description
2


201000003450
persistent generalized lymphadenopathy
Diseases




0.000
description
2


229950001046
piroctone
Drugs




0.000
description
2


229940081510
piroctone olamine
Drugs




0.000
description
2


239000010773
plant oil
Substances




0.000
description
2


229920001921
poly-methyl-phenyl-siloxane
Polymers




0.000
description
2


229920000573
polyethylene
Polymers




0.000
description
2


229920001223
polyethylene glycol
Polymers




0.000
description
2


229920000136
polysorbate
Polymers




0.000
description
2


230000002035
prolonged
Effects




0.000
description
2


230000001737
promoting
Effects




0.000
description
2


PZQSQRCNMZGWFT-QXMHVHEDSA-N
propan-2-yl (Z)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C
PZQSQRCNMZGWFT-QXMHVHEDSA-N
0.000
description
2


NEOZOXKVMDBOSG-UHFFFAOYSA-N
propan-2-yl 16-methylheptadecanoate
Chemical compound


CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C
NEOZOXKVMDBOSG-UHFFFAOYSA-N
0.000
description
2


239000004172
quinoline yellow
Substances




0.000
description
2


229940051201
quinoline yellow
Drugs




0.000
description
2


235000012752
quinoline yellow
Nutrition




0.000
description
2


WECGLUPZRHILCT-HZJYTTRNSA-N
rac-1-monolinoleoylglycerol
Chemical compound


CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(O)CO
WECGLUPZRHILCT-HZJYTTRNSA-N
0.000
description
2


GGJRAQULURVTAJ-PDBXOOCHSA-N
rac-1-Î±-linolenoylglycerol
Chemical compound


CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OCC(O)CO
GGJRAQULURVTAJ-PDBXOOCHSA-N
0.000
description
2


230000002940
repellent
Effects




0.000
description
2


235000020944
retinol
Nutrition




0.000
description
2


239000011607
retinol
Substances




0.000
description
2


229960000342
retinol acetate
Drugs




0.000
description
2


235000019173
retinyl acetate
Nutrition




0.000
description
2


239000011770
retinyl acetate
Substances




0.000
description
2


QGNJRVVDBSJHIZ-QHLGVNSISA-N
retinyl acetate
Chemical compound


CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
QGNJRVVDBSJHIZ-QHLGVNSISA-N
0.000
description
2


235000019172
retinyl palmitate
Nutrition




0.000
description
2


239000011769
retinyl palmitate
Substances




0.000
description
2


239000010669
rosewood oil
Substances




0.000
description
2


IKGXIBQEEMLURG-NVPNHPEKSA-N
rutin
Chemical compound


O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1
IKGXIBQEEMLURG-NVPNHPEKSA-N
0.000
description
2


235000005493
rutin
Nutrition




0.000
description
2


229930002876
rutin
Natural products




0.000
description
2


229960004555
rutoside
Drugs




0.000
description
2


150000003839
salts
Chemical class




0.000
description
2


230000037394
skin elasticity
Effects




0.000
description
2


230000004215
skin function
Effects




0.000
description
2


239000000344
soap
Substances




0.000
description
2


239000011780
sodium chloride
Substances




0.000
description
2


239000001589
sorbitan tristearate
Substances




0.000
description
2


235000011078
sorbitan tristearate
Nutrition




0.000
description
2


229960004129
sorbitan tristearate
Drugs




0.000
description
2


239000007921
spray
Substances




0.000
description
2


229940032094
squalane
Drugs




0.000
description
2


239000003381
stabilizer
Substances




0.000
description
2


235000003702
sterols
Nutrition




0.000
description
2


150000003432
sterols
Chemical class




0.000
description
2


238000003756
stirring
Methods




0.000
description
2


239000010678
thyme oil
Substances




0.000
description
2


229950009883
tocopheryl nicotinate
Drugs




0.000
description
2


ILJSQTXMGCGYMG-UHFFFAOYSA-M
triacetate(1-)
Chemical compound


CC(=O)CC(=O)CC([O-])=O
ILJSQTXMGCGYMG-UHFFFAOYSA-M
0.000
description
2


LADGBHLMCUINGV-UHFFFAOYSA-N
tricaprin
Chemical compound


CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC
LADGBHLMCUINGV-UHFFFAOYSA-N
0.000
description
2


229960003500
triclosan
Drugs




0.000
description
2


229950004578
vitamin A palmitate
Drugs




0.000
description
2


235000019386
wax ester
Nutrition




0.000
description
2


239000010497
wheat germ oil
Substances




0.000
description
2



Classifications




A—HUMAN NECESSITIES


A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE


A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES


A61K8/00—Cosmetics or similar toiletry preparations


A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition


A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof


A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin








A—HUMAN NECESSITIES


A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE


A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS


A61Q19/00—Preparations for care of the skin







A—HUMAN NECESSITIES


A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE


A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS


A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings


A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations








Abstract

The invention relates to fatty skin oils containing at least one oil-soluble constituent, at least one O/W-emulsifier having and HLB value of between 2 and 6, preferably between 2 and 5, 9, and optionally at least one additive selected from ethereal oils, antioxidants, scented substances, preservatives, active ingredients, UV filters, vitamins, thickeners, and solubilisers. The invention also relates to the production of said oils and the use of the same as skin oils, especially as skin care oils, sport oils, massage oils or sun oils. Said skin oils can be applied to dry skin and especially lo wet skin, having a self-emulsifying action and the advantages related thereto, soaking easily into the skin without leaving an unwanted greasy film. 




Description


   The present invention relates to fat-containing skin oils comprising one or more oil-soluble components, one or more W/O emulsifiers with an HLB value of 2-6, preferably 2-5.9, and optionally one or more additives chosen from essential oils, antioxidants, perfume substances, preservatives, active ingredients, UV filters, vitamins, consistency modulators, solubilizers, to their preparation and also to their use as skin oil, in particular as skincare oil, skin protection oil, sport oil, massage oil, or sunscreen oil. These skin oils can be applied to dry skin and, in particular, to wet skin, where they have a self-emulsifying effect and have the advantages associated therewith as a result of the ready absorption into the skin without leaving behind an undesired greasy film. [0001]  
    Skin oils have established a firm place in the broad pallet of cosmetic care products. They have the task of compensating for the deficit of skin lipids, of making the skin soft and supple, of promoting skin elasticity or of protecting the skin through the formation of a hydrophobic film. For massages, they are used as lubricants. [0002]  
    By incorporating specific active ingredients, so-called skin function oils, e.g. sunscreen oils, sport oils, can be formulated. [0003]  
    These are liquid, oily preparations which are prepared by mixing various fats and oils, waxes, fatty acid esters and liquid hydrocarbons or silicone oils. [0004]  
    In addition, stabilizers, such as antioxidants, preservatives or specific active ingredients, such as UV filters, vitamins, essential oils or plant extracts, can be incorporated. The so-called hydrophilic oils additionally comprise an O/W emulsifier and can be washed off with water as a result of the formation of an O/W emulsion. [0005]  
    Such customary skin oils are also described in the monograph by K. Schrader, Grundlage und Rezepturen der Kosmetika [fundamentals and formulations of cosmetics], 2nd Edition (1989, HÃ¼thig Buchverlag), pp. 525-528. [0006]  
    The âHandbuch der Kosmetika und Riechstoffeâ [handbook of cosmetics and fragrances], Vol. III, 1973, pp. 482-489 (Dr. A. HÃ¼thig Verlag Heidelberg) describes various skin oils. Examples of components which can be used are: non-drying oils, mineral oils of varying viscosity, isopropyl myristate and isopropyl palmitate, deodorized isopropyl oleate, isopropyl isostearate, liquid hexadecyl alcohol, hexadecyl isostearate, high-purity oleyl alcohol (HD-Eutanol), cetiol LG, cetiol HE, myritol 318, cremogen HP, Miglyol 812, cetiol B, oleyl oleate, decyl oleate (cetiol V), perhydrosqualene (Cosbiol), liquid acetoglycerides, amerchol L-101, Acetulan (American cholesterol), lanolin derivatives (e.g. liquid lanolin; Modulan etc.), isohexadecyl palmitostearate (Wickenol 1109-H), cetyl polypropylene glycol ether (P.R.O. cetyl alcohol 30), lanolin alcohol polypropylene glycol ether (P.R.O. lanolin alcohol 30), hexadecyl polypropylene glycol ether (P.R.O. hexadecyl alcohol 30), silicone oils, propylene glycol diperlargonate (Emery 3771-D). [0007]  
    The additives described are, especially generally, the following âactive ingredientsâ: [0008]  
    lecithins, liquid lanolin and lanolin derivatives, oily drug extracts (camomile, arnica, hypericum, calendula), oily skin extracts (and gland extracts), camphor, menthol, camphor phenoxide, ichthyol (oil-soluble), aluminum stearate (also as thickener), liquid polyethylene glycol mono fatty acid esters, vitamins (A, D[0009]  3, E etc.), Î²-carotene, chlorophyll, oil-soluble. 
    In particular, a face oil consisting of olive oil, eutanol G, neoba O, lecithin oil, purcellin oil, perfume, color, preservatives is disclosed. Also described are various massage oils, body oils and sport oils which comprise predominantly paraffin oil (cf. pp. 487-488). [0010]  
    Also described are skin oils which can be washed off which have the abovementioned O/W emulsifiers, cf. also Janistyn, H., âHandbuch der Kosmetika und Riechstoffeâ [handbook of cosmetics and fragrances], 3rd Vol. 1972, Dr. Alfred HÃ¼thig Verlag, pp. 483-489, which specifies an oil consisting of olive oil, isopropyl myristate and sorbitan sesquioleate/trioleate. [0011]  
    SÃFW, 115 (1989), pp. 344-350 discloses general bases for the preparation of anhydrous products and also describes skin oils. These are characterized as lipid-containing anhydrous liquid preparations [lacuna] can additionally have an O/W emulsifier with an HLB value greater than 8. The oil components described here are the customary paraffins or e.g. octyldodecanol, myritol 318, cetiol, Miglyol and also optionally liquid lanolin, phenylmethylsilicone. Reportedly, these skin oils are, in particular, water-repellent (cf. p. 345, point 2.1.1.2.6). [0012]  
    SÃFW, 98 (1972), pp. 889-891 describes hydrophilic oils which, as well as the customary oil components, have nonionic emulsifiers, such as polyoxyethylated laurates/oleates and corresponding sorbitan derivatives with an HLB value of 8-11. Such polyoxyethylated products are, as is known, O/W emulsifiers and reportedly form O/W emulsions. These also include combinations of emulsifiers with a total HLB value of from 8 to 11, such as, for example, the combination of ArlaconeÂ® T (HLB=9.2), TweenÂ® 85 (HLB=11.0) and SpanÂ® 85 (HLB=1.8). [0013]  
    EP-A 0 467 218 describes lipid combinations which have at least two of the following components: unsaturated fatty acids and/or their tocopheryl esters; n-alkanes; squalene; cholesterol and/or wool wax alcohol; triglyceride; wax esters. Particular preference is given to combinations of unsaturated fatty acids/cholesterol/wool wax alcohol. These combinations can reportedly be used as they are or in a hydrous base spread on the skin. [0014]  
    DE 31 41 761 relates to glucose derivatives and to cosmetic products comprising these, where the former are used as surface-active substances. [0015]  
    Liposome-containing care and cleansing formulations are described in EP No. 0 523 418, EP 0 557 825, DE 198 54 827. These are generally hydrogels, O/W emulsions or washing products. For example, EP-B 0 557 825 describes oil-containing bath and shower additives consisting of oil components, vesicle-forming lipids and O/W surfactants with an HLB value of 6-13. These compositions are cleansing products. EP-B 0 523 418 relates to liposome-containing creams with oil phase and water phase and certain polyoxyethylated surfactants as emulsifiers with HLB values of 9-13. However, these do not achieve the care action of a skin oil. Furthermore, in the case of skincare products, vesicles are usually only prepared by complex processes and incorporated into the desired preparation. Stability problems may arise, particularly in the case of emulsions. [0016]  
    DE 198 54 827 relates to surfactant-containing cleansers which are oil-free and have sterols as liposome formers. [0017]  
    An object of the present invention is therefore to provide oil-containing products which can also be applied to wet skin, have a self-emulsifying action, so that a care effect as during rubbing in is achieved without the skin being subjected beforehand to drying and without the greasy film customary with skin oils being present, which is or can only be removed after a prolonged time or, where appropriate, only by rubbing or washing off. [0018]  
    This object is achieved according to the invention by skin oil compositions comprising one or more oil-soluble components and one or more W/O emulsifiers with an HLB value of 2-6, and optionally one or more additives chosen from active ingredients, antioxidants, perfume substances, preservatives, UV filters, vitamins, dyes, solubilizers, consistency modulators, with the exception of compositions comprising cholesterol and/or wool wax alcohol. [0019]  
    If said oil components are combined with the described W/O emulsifiers, it has been found that, upon application, in particular to wet skin, the oil has a self-emulsifying effect and thus is easy to apply and also is without an undesired greasy film. This could not be expected since here overall only a small amount of water is present and no apparatuses customary for the preparation of emulsions, in particular stirrers or high-speed homogenizers, are used. [0020]  
    In the skin oil composition according to the invention, the oil-soluble component(s) is/are present in an amount of 50-99%, the W/O emulsifier(s) is/are present in an amount of 0.5-10% and the additive(s) are present in an amount of 0-40%, in particular 0.1-40%, preferably 0.5-20% and very particularly preferably 1-15% in total. [0021]  
    According to the invention, the emulsifier(s) can be present in amounts of 0.5-10%, in particular from 1.0-8% and very preferably 2-5%. The oil component(s) and additives are present here in amounts of 50-99%, preferably 70-97% and in particular 85-97%. [0022]  
    In a particularly preferred embodiment, the compositions can one or more W/O emulsifiers (alone or in a mixture with one another) with an HLB value of in particular 3-5.5 and very particularly from 3.5-5.5 be used [sic]. [0023]  
    The emulsifier(s) is present here in the amounts given. [0024]  
    In a further preferred embodiment, oil component(s) is/are present in an amount of 85-97%, the emulsifier(s) is/are present in an amount of 1-10%, in particular 2-6% and the additives are present in an amount of 1-20%, in particular 1-15%. [0025]  
    Particularly preferred emulsifiers are the following, the HLB value being given in brackets in each case: [0026]  
    Sorbitan Derivatives: [0027]  
    Sorbitan esters, such as sorbitan oleate (SpanÂ® 80, HLB=4.5), sorbitan stearate (HLB=5.0), sorbitan sesquioleate (CrillÂ® 43, HLB=3.7), sorbitan isostearate (CrillÂ® 6, HLB=4.7), sorbitan tristearate (Crill 35Â®, HLB=2.1); [0028]  
    Polyethoxylated Products [0029]  
    Polyethoxylated fatty acids and fatty alcohols, such as PEG-2 oleate (HLB=5.0), PEG-4 distearate (HLB=3.0), PEG-2 stearate (HLB=4.4), ceteareth-3 (VolpoÂ® CS3, HLB=5.0), ceteth-2 (VolpoÂ® C2, HLB=5.3); ethoxylated triglycerides, such as PEG-5 castor oil (HLB=3.9), PEG-6 diricinoleate (HLB=5.0), PEG-7 hydrogenated castor oil (CremophorÂ® WO 7, HLB=5.0); [0030]  
    (Poly)Glyceryl Derivatives [0031]  
    Polyglyceryl esters, such as polyglyceryl-3 diisostearate (LameformÂ® TGI, HLB=3.5), polyglyceryl-2 dipolyhydroxystearate (DehymulsÂ® PGPH, HLB=3.5), diisostearoyl polyglyceryl-3 diisostearate (IsolanÂ® PDI, HLB ca. 5), polyglyceryl-3 oleate (IsolanÂ® GO 33, HLB ca. 5), polyglyceryl-3 dioleate (CremophorÂ® GO 32, HLB ca. 5), polyglyceryl-4 isostearate (IsolanÂ® GI 34, HLB ca. 5); [0032]  
    glycerin esters, such as glyceryl ricinoleate (CithrolÂ® GMR N/E, HLB=2.7), glyceryl laurate (CithrolÂ® GML N/E, HLB=4.9), glyceryl dioleate S/E (CithrolÂ® GDO S/E, HLB=2.9); [0033]  
    Polyol Esters [0034]  
    Polyol esters, such as glycol oleate S/E (CithrolÂ® EGMO S/E, HLB=2.7), glycol ricinoleate (CithrolÂ® EGMR S/E, HLB=2.0), glycol dilaurate S/E (CithrolÂ® EGDL S/E, HLB=2.0), propylene glycol ricinoleate (CithrolÂ® PGMR S/E, HLB=3.6), propylene glycol laurate (CithrolÂ® PGML N/E, HLB=2.7); [0035]  
    Glucose Derivatives [0036]  
    Glucose esters, such as methyl glucose dioleate (IsolanÂ® DO, HLB ca. 5), methyl glucose isostearate (IsolanÂ® IS, HLB ca. 5); [0037]  
    Pentaerythritol Derivatives [0038]  
    Pentaerythritol fatty acid esters, e.g. pentaerythritol monolaurate (HLB=4.8), pentaerythritol monotallate (HLB=4.0) or mixed esters, e.g. with citric acid fatty alcohol esters such as [0039]  
    DehymulsÂ® E (dicocoyl pentaerythrityl distearyl citrate, sorbitan sesquioleate, Cera alba, aluminum stearate, HLB=4.0), DehymulsÂ® F (dicocoyl pentaerythrityl distearyl citrate, Cera microcristallina, glyceryl oleate, aluminum stearate, propylene glycol (HLB=4.0); [0040]  
    Alkylphenols [0041]  
    Alkyphenols, e.g. nonoxynol-2 (HLB ca. 4.5); [0042]  
    Polymers [0043]  
    Polymers such as polyoxypropylene-polyoxyethylene block polymers (INCI name: Poloxamers), e.g. PluronicÂ® PE 3100 (HLB=4.5), PluronicÂ® PE 6100 (HLB=3.0) or PEG-30 dipolyhydroxystearate (ArlacelÂ® P 135, HLB ca. 5.5); [0044]  
    Siloxane Derivatives [0045]  
    Polysiloxane copolymers, in particular those mentioned below from this group. [0046]  
    Preference is given to ethoxylated products, such as fatty acids and triglycerides, such as PEG-2 oleate, PEG-7 hydrogenated castor oil (CremophorÂ® WO 7), (poly)glyceryl ester and glucose ester, and polysiloxane copolymers or mixtures thereof. [0047]  
    Particular preference is given to polysiloxane copolymers, such as polysiloxane-polyether copolymers, in particular polysiloxane-polyalkyl-polyether copolymers, such as cetyl dimethicone copolyol (AbilÂ® EM 90, HLB ca. 5), laurylmethicone copolyol (Dow CorningÂ® Q2-5200, HLB ca. 4). [0048]  
    Also particularly preferred are emulsifier mixtures containing siloxane derivatives, such as standard commercial AbilÂ® WE 90 (HLB ca. 5) consisting of cetyl dimethicone copolyol, polyglyceryl-4 isostearate and hexyl laurate. [0049]  
    Alternatively, it is also possible to combine individual emulsifiers from in each case one of the said groups or else from different groups, where combinations of polysiloxane copolymers and polyglyceryl esters are preferred. [0050]  
    Suitable as oil components are customary, preferably liquid, lipids, these may be present individually or in a mixture. In particular, the following groups and examples thereof are suitable: [0051]  
    Hydrocarbons, such as squalene, squalane, in particular liquid paraffins, isoparaffins or else dioctylcyclohexane (CetiolÂ® S), isohexadecane (ArlamolÂ® HD). [0052]  
    Fatty alcohols, such as oleyl alcohol, octyldodecanol (EutanolÂ® G) [0053]  
    Fatty acid esters, e.g. isopropyl fatty acid esters (palmitate, myristate, isostearate, oleate), decyl oleate (CetiolÂ® V), hexyl laurate, C12-15 alkylbenzoate (FinsolvÂ® TN), dicaprylyl carbonate (CetiolÂ® CC), diesters, such as dibutyl adipate (CetiolÂ® B), propylene glycol dipelargonate, branched fatty acid esters, such as PCL-liquidÂ® (cetearyl octanoate) or mixtures such as CetiolÂ® PGL (hexyldecanol and hexyldecyl laurate) [0054]  
    Fatty alcohol ethers, such as dicaprylyl ether (CetiolÂ® OE) [0055]  
    Polyol fatty acid esters, such as CetiolÂ® HE (PEG-7 glyceryl cocoate) [0056]  
    Triglycerides, in particular medium-chain (neutral oils), such as caprylic/capric triglyceride (MiglyolÂ® 810, 812)., and, in particular, their polyol esters, such as propylene glycol dicaprylate/dicaprate (MiglyolÂ® 840). [0057]  
    Natural fats and oils, such as sunflower oil, soybean oil, peach kernel oil, apricot kernel oil, grape seed oil, castor oil, groundnut oil, almond oil, clove oil, wheat germ oil, avocado oil. [0058]  
    Natural liquid waxes, e.g. jojoba oil or its substitute oleyl erucate (CetiolÂ® J 600). [0059]  
    Silicone oils and silicone waxes, e.g. polydimethylsiloxanes, such as Dow Corning FluidÂ® 200 (dimethicone), cyclomethylsiloxanes, such as Dow Corning FluidÂ® 345 (cyclomethicone), phenylmethylpoly-siloxanes, such as phenyl dimethicone (AbilÂ® AV 8853) or alkyl-polymethylsiloxane copolymers, such as cetyl dimethicone (AbilÂ® Wax 9801), stearyl dimethicone (AbilÂ® Wax 9800), dialkoxydimethylpolysiloxanes, such as stearoxy dimethicone (AbilÂ® Wax 2434), behenoxy dimethicone (AbilÂ® Wax 2440) [0060]  
    Particularly preferred oil components are liquid paraffins, fatty acid esters, such as isopropyl palmitate or myristate, medium-chain triglycerides, such as the abovementioned Miglyols, in particular their polyol esters, and said natural fats and oils, in particular sunflower oil, soybean oil, peach kernel oil, apricot kernel oil, in particular mixtures thereof, and also jojoba oil, its mixtures with the abovementioned oil components, where, in each case, ca. 1-40% of individual component, based on the total amount, are present, or fatty alcohol ethers or fatty alcohols or mixtures thereof or hydrogenated oils such as perhydrosqualene, in each case individually or combined. [0061]  
    Particularly preferably, said liquid paraffins and said triglycerides are also in combination with one another. [0062]  
    Also suitable are the abovementioned dioctylcyclo-hexanes, isohexadecanes, in particular the latter, silicone oils and silicone waxes, in particular also combinations thereof and also with the abovementioned paraffins and triglycerides. These can then in particular also be combined primarily with the natural fats, oils and waxes. [0063]  
    According to the invention, it is preferred if the oil composition, as well as having the main components oil/emulsifier, has as additional substances active ingredients, which also include essential oils and plant extracts, preservatives and vitamins. [0064]  
    Suitable vitamins are, in particular, vitamin A, E, C and derivatives thereof, e.g. retinol, retinol acetate, or retinol palmitate, carotinoids, tocopherol or tocopherol acetate, ascorbyl palmitate. [0065]  
    The active ingredients are preferably chosen from essential oils and terpenes, e.g. rosemary oil, orange oil, lavender oil, lime oil, cinnamon oil, geranium oil, cedarwood oil, rosewood oil, valerian oil, ylang ylang oil, eucalyptus oil, mint oil, lemongrass oil, cypress oil, niaouli oil, spruce needle oil, pine needle oil, camphor, menthol. [0066]  
    In addition, it is also possible here to use essential unsaturated fatty acids and esters thereof, e.g. linoleic acid or linolenic acid, glyceryl linoleate, glyceryl linolenate. [0067]  
    Instead of or as well as the abovementioned active ingredients, it is also possible to use circulation-promoting substances, e.g. nicotinic acid derivatives, such as methyl or tocopheryl nicotinate, alpha- and betahydroxy acids and derivatives thereof, e.g. salicylic acid, isopropylbenzyl salicylates, C12-13 alkyl lactates (CosmacolÂ® ELI) or else antiphlogistic and antibacterial substances, such as glycyrrhizinic acid or glycyrrhetinic acid and derivatives thereof, e.g. stearyl glycyrrhetinate, panthothenic acid derivatives, e.g. panthenyl triacetate, allantoin, bisabolol, azulenes, e.g. chamazulenes or guaiazulene, triclosan, chlorhexidine derivatives and/or antidandruff agents, e.g. climbazole or piroctone olamine. [0068]  
    In addition, repellents, such as N,N-diethyl-m-toluamide or dimethyl phthalate; [0069]  
    or substances with an antioxidative and cell-protecting effect, such as flavonoids, e.g. rutin, ferulic acid and esters thereof or coenzyme Q 10, can also be used as effective additives in the skin oils according to the invention. [0070]  
    It is also possible to use plant extracts, which themselves may also be active ingredients, such as, for example, Aloe vera extract, lime blossom extract, Centalla asiatica extract, ivy leaf extract, can be used as effective additives [sic]. [0071]  
    Said components can also be combined, depending on the desired intended use. For example, combinations of aromatherapeutically effective essential oils, such as rosemary oil, lime oil and/or lemongrass oil, or valerian oil, lavender oil and/or ylang ylang oil or circulation-promoting substances, such as rosemary oil and methyl nicotinate, in particular, are preferred. [0072]  
    Particularly preferred active ingredients are chosen from essential oils and terpenes, plant extracts, circulation-promoting substances, antiphlogistic and antibacterial substances, vitamins, essential unsaturated fatty acids or mixtures thereof. [0073]  
    Further particularly suitable additives from the group of active ingredients, which may also be essential oils as described above and can also represent perfume substances at the same time, are, in particular, mint oil, lime oil, orange oil, juniper oil, valerian oil, eucalyptus oil, thyme oil, palmarosa oil, rosemary oil, lavender oil, menthol, ginger extract, lime blossom extract, marigold extract, algae extract, Aloe vera extract, Echinacea extract, ivy leaf extract, hydroxyethyl salicylate, methyl salicylate, nicotinic esters or combinations thereof, such as, for example, orange oil, lavender oil, palmarosa oil and valerian oil or juniper oil, hydroxyethyl salicylate and methyl nicotinate. In this connection, depending on the intended effect, such as, for example, improvement in the hair structure, increase in circulation, tension relief, aromatherapy or the like, a suitable combination of active ingredients can be added. Where appropriate, further refatting agents, such as fatty acid glycerides and ethoxylates thereof, e.g. PEG-6 caprylic/capric glycerides (SoftigenÂ® 767), can be added. [0074]  
    It is, moreover, preferred if the skin oil composition comprise [sic], additionally or alternatively to the three abovementioned addition variants, as additive, those chosen from antioxidants, perfume substances, dyes and/or UV filters. [0075]  
    The antioxidants can then preferably be chosen from butylhydroxytoluene, butylhydroxyanisole, ascorbyl, palmitate, tocopherol, possibly in combination with synergistic agents, such as in ControxÂ® VP (tocopherol, lecithin, ascorbyl plamitate, hydrogenated palm glycerides citrate), or else gallic alkyl esters, such as octyl, dodecyl and cetyl gallate or combinations thereof. [0076]  
    Particularly preferred perfume substances are also standard commercial perfume compositions as well as the, for example, essential oils specified under âactive ingredientsâ. [0077]  
    Preferred dyes are, for example, Patent Blue, Amidoblue, Orange RGL, cochenille red, quinoline yellow, in particular to connect with a suitable solubilizer. This can be chosen, in particular, from ethanol and isopropanol, e.g. in amounts of 5-30%, in particular 5-15%. [0078]  
    Particularly preferred dyes are carotinoids, e.g. alpha- or beta-carotene or azulenes, such as chamazulene or guaiazulene. [0079]  
    Suitable UV filters are are [sic] oil-soluble UVB, UVA and broadband filters of the following type: [0080]  
    UV-B filters: cinnamic esters, e.g. octyl methoxycinnamate (EusolexÂ® 2292, Neo HeliopanÂ®D AV, ParsolÂ® MCX), isoamyl p-methoxycinnamate (Neo HeliopanÂ® Galanga) and 4-methylbenzylidenecamphor (EusolexÂ® 6300), paraaminobenzoic acid and esters, such as 2-ethylhexyl N,N-dimethyl-4-aminobenzoate (EusolexÂ® 6007, octyl dimethyl PABA), homomenthyl salicylate (homosalate, EusolexÂ® HMS), octyl salicylate (Neo HeliopanÂ® OS), octocrylene (Neo HeliopanÂ® 303), butylmethoxydibenzoylmethane (EusolexÂ® 9020); UVA and UVB filters for broadband absorption, such as benzophenone-3 (NeoÂ® Heliopan BB, EusolexÂ® 4360); UV-A filters, such as methyl anthranilate (Neo HeliopanÂ® MA) [0081]  
    Particular preference is given to octyl methoxy-cinnamate, octocrylene, 4-methylbenzylidenecamphor, homosalate and/or methyl anthranilate and/or benzophenone-3. [0082]  
    Suitable preservatives are iodopropynyl butylcarbamate, phenoxyethanol and further customary preservatives, such as, for example, sorbic acid and dehydracetic acid and salts thereof, methyldibromoglutanonitrile [sic], etc. or combinations thereof, or other acids, such as benzoic acid or salicylic acid, or benzyl alcohol or esters, such as p-hydroxybenzoic esters, e.g. methyl-, ethyl-, propyl-, butyl-, isobutylparaben, preferably methyl- or propylparaben or mixtures thereof or climbazole or suitable combinations of said substances, such as, for example, methylparaben, propylparaben and sorbic acid. [0083]  
    The emulsifier-containing skin oil compositions according to the invention have a particular primarily self-emulsifying effect, in particular when applied to wet skin, coupled with better moisture storage, better rubbing in to the skin without an unpleasant greasy film feel, which results in particular from the combination according to the invention of oil component and W/O emulsifier. [0084]  
    Preferred combinations of oil/emulsifier comprise: [0085]  
    paraffin oil (20-40%) and/or Miglyol 812 (20-30%) and/or isopropyl palmitate (15-25%); or else additionally to this jojoba oil (1-5%) and/or peach kernel oil (3-5%) [0086]  
    and as emulsifier AbilÂ® EM 90 and/or AbilÂ® WE 09. [0087]  
    For this purpose it is possible to use the abovementioned additives, in particular said combinations, and very particular preference is given to using essential oils, perfume oils and/or circulation-promoting substances and also plant extracts and UV filters. [0088]  
    If the oil according to the invention have [sic] a relatively thin-liquid consistency, 5-30%, or preferably 5-15%, of ethanol or isopropanol can also be added as consistency modulator, in particular ethanol. These can also serve as solubilizers for other substances. [0089]  
    Conversely, the consistency modulator added may also be thickeners and/or substances for improving the feel on the skin or the water resistance, such as, for example, polyethylene waxes with a molar mass of 1500 to 20,000, such as LunaceraÂ® PA Paste, AerosilÂ®, modified montmorillonite, such as MiglyolÂ® Gel B (caprylic/capric triglycerides, stearalkonium hectorite, propylene carbonate), aluminum soaps, and their modifications, e.g. aluminum/magnesium hydroxide stearate, alkylated polyvinylpyrrolidones, such as AntaronÂ® V-216. (PVP/hexadecane copolymer) and AntaronÂ® V-220 (PVP/eicosene copolymer). [0090]  
    If certain purposes are intended, e.g. skincare oil, sport oil or sunscreen oil or massage oil, the additives are chosen accordingly, e.g. for skincare oil, vitamins, plant oils and/or plant extracts, [0091]  
    for sport oil, circulation-promoting substances, such as methyl nicotinate and/or hydroxyethyl salicylate and/or essential oils, e.g. rosemary oil for sunscreen oil, UV-A and UV-B and also broadband filters, and vitamins, such as vitamin A and vitamin C for massage oil, essential oils which have an aromatherapeutic and/or circulation-promoting effect, such as orange oil, lavender oil, palmarosa oil, lime oil, lemongrass oil, and/or vitamin A, vitamin E where additionally preservatives, antioxidants and/or perfume substances may be present in the amounts stated. [0092]  
    The invention is described in more detail by reference to Examples 1-5 below. [0093]  
    The compositions according to the invention were prepared by stirring the liquid oils (if present) in a suitable vessel until homogeneous at room temperature, where necessary heating them to 40-90Â° C. in order to melt any solid waxes or fats present. The emulsifier(s) were then incorporated. [0094]  
    After cooling to room temperature, in particular 25Â° C., the additives, where present, were incorporated and stirred to homogeneity. [0095]  
    Where necessary, solid components can also be heated beforehand in a suitable manner, and then the nonsolid constituents be added at a suitable temperature (25-50Â° C., in particular 25-40Â° C.).[0096]  
 
EXAMPLE 1 
Skin Oil 
    [0097]                    Raw materials 100% formulation                  Miglyol 812 38.50     Peach kernel oil 3.00     Jojoba oil 1.00     Tocopherol acetate 1.10     Paraffin oil, thick-liquid 28.40     Isopropyl palmitate 25.00     AbilâÂ® EM 90: cetyldimethicone copolyol 2.00     Perfume oil 1.00     TOTAL 100.00                       
 EXAMPLE 2 
Skin Oil 
    [0098]                    Raw materials 100% formulation                  Miglyol 812 37.90     Peach kernel oil 4.00     Tocopherol acetate 1.10     Paraffin oil, thick-liquid 28.40     Isopropyl myristate 25.00     AbilâÂ® EM 90: cetyldimethicone copolyol 2.00     Rosemary oil 0.30     Grapefruit oil 0.20     Niaouli oil 0.10     Perfume oil 1.00     TOTAL 100.00           
 EXAMPLE 3 
Oil-Based Skin Sunscreen Spray 
    [0099]                    Raw materials 100% formulation                  Paraffin oil, thin-liquid 50.50     FinsolvâÂ® TN: C12-C15-alkyl benzoate 12.00     CetiolâÂ® OE: dicaprylyl ether 10.00     Miglyol 812 20.00     AbilâÂ® EM 90: cetyldimethicone copolyol 2.00     UV filter: Neo HeliopanâÂ® AV; octyl 5.00     methoxycinnamate     Perfume oil 0.50     TOTAL 100.00           
 EXAMPLE 4 
Skin Oil 
    [0100]                    Raw materials 100% formulation                  Miglyol 812 39.00     Peach kernel oil 3.00     Jojoba oil 1.00     Tocopherol acetate 1.10     Paraffin oil, thick-liquid 28.40     Isopropyl palmitate 25.00     DehymulsâÂ® PGPH: polyglyceryl-2 2.00     dipolyhydroxystearate     Perfume oil 0.50     TOTAL 100.00           
 EXAMPLE 5 
Skin Oil 
    [0101]                    Raw materials 100% formulation                  Miglyol 812 39.00     Peach kernel oil 3.00     Tocopherol acetate 1.10     Paraffin oil, thick-liquid 28.40     Isopropyl palmitate 26.00     IsolanâÂ® PDI: diisostearylpolyglyceryl-3 2.00     diisostearate     Perfume oil 0.50     TOTAL 100.00           
 



Claims (18)

 
 1) A skin oil comprising one or more oil-soluble components and one or more W/O emulsifiers with an HLB value of 2-6, and optionally one or more additives, chosen from active ingredients, antioxidants, perfume substances, preservatives, UV filters, vitamins, dyes, consistency modulators, solubilizers, with the exception of compositions comprising cholesterol and/or wool wax alcohol. 

  
 2) The skin oil as claimed in claim 1, characterized in that the oil-soluble component(s) is/are present in an amount of 50-99%, the emulsifier(s) is/are present in an amount of 0.5-10% and the additive(s) is/are present in an amount of 0-40% in total. 

  
 3) The skin oil as claimed in claim 1 or 2, characterized in that the emulsifier(s) is/are chosen from sorbitan derivatives, polyethoxylated products, (poly)glyceryl derivatives, polyol esters, glucose derivatives, pentaerythritol derivatives, alkylphenols, polymers and siloxane derivatives or mixtures thereof. 

  
 4) The skin oil as claimed in any of claims 1-3, characterized in that the oil component(s) is/are chosen from hydrocarbons, fatty alcohols, fatty acid esters, fatty alcohol ethers, polyol fatty acid esters, triglycerides, natural fats, oils or natural liquid waxes or silicone oils or silicone waxes or mixtures thereof. 

  
 5) The skin oil as claimed in any of claims 1-4, characterized in that the oil component is chosen from liquid paraffin, isopropyl palmitate, medium-chain triglycerides, sunflower oil, soybean oil, peach kernel oil, apricot oil, jojoba oil, silicone oils or mixtures of the abovementioned components. 

  
 6) The skin oil as claimed in any of claims 1-5, characterized in that the emulsifier(s) is/are chosen from ethoxylated products, (poly)glyceryl esters, glucose esters or polysiloxane copolymers or mixtures thereof. 

  
 7) The skin oil as claimed in any of claims 1-6, characterized in that the W/O emulsifier(s) is/are present in an amount of 1.0-8%. 

  
 8) The skin oil as claimed in any of claims 1-7, characterized in that the W/O emulsifier(s) has/have an HLB value of 2-5.9. 

  
 9) The skin oil as claimed in claim 8, characterized in that the W/O-emulsifier(s) has/have an HLB value of 3.5-5.5. 

  
 10) The skin oil as claimed in any of claims 1-9, characterized in that cetyl dimethicone copolyol or cetyl dimethicone copolyol in a mixture with polyglyceryl-4 isostearate and hexyl laurate is present as emulsifier. 

  
 11) The skin oil as claimed in any of claims 1-10, characterized in that the skin oil has active ingredients, preservatives and vitamins as additives. 

  
 12) The skin oil as claimed in any of claims 1-11, characterized in that the skin oil has, as additives, those chosen from antioxidants, perfume substances, dyes, UV filters, as additives. 

  
 13) The skin oil as claimed in claim 11 or 12, characterized in that the active ingredients are chosen from essential oils and terpenes, plant extracts, circulation-promoting substances, antiphlogistics and antibacterial substances or mixtures thereof. 

  
 14) The skin oil as claimed in any of claims 1-13, characterized in that the perfume(s) is/are standard commercial perfume oil compositions, the preservative(s) is/are chosen from methylparaben or propylparaben or mixtures thereof, the anti-oxidants are chosen from butylhydroxytoluene, butylhydroxyanisole, ascorbyl palmitate, tocopherol or mixtures thereof with synergistic agents, the vitamins are chosen from vitamin E, vitamin A, vitamin C and derivatives thereof. 

  
 15) The skin oil as claimed in any of claims 1-14, characterized in that the oil component(s) is/are present in an amount of 85-97%, the W/O emulsifier(s) is/are present in an amount to 2-6% and the additives are present in an amount of 1-15%. 

  
 16) The skin oil as claimed in any of claims 1-15, characterized in that ethanol is present as solubilizer. 

  
 17) A process for the preparation of skin oils as claimed in any of claims 1-16, characterized in that the oil component(s) is/are mixed at room temperature and optionally heated to 40-90Â° C., the emulsifier(s) is/are incorporated, then the mixture is cooled to room temperature and then the additive(s) is/are incorporated. 

  
 18) The use of skin oils as claimed in any of claims 1-16 as skincare oil, skin protection oil, sport oil, massage oil or sunscreen oil.

 




US10/450,542
2000-12-15
2001-11-02
Skin oils consisting of oil-soluble constituents and w/o-emulsifiers having an hlb value of between 2 and 6 and optionally at least one standard additive, method for the production thereof and use of the same 
       
Abandoned

US20040067206A1
            (en)
        

Applications Claiming Priority (3)



Application Number
Priority Date
Filing Date
Title





DE10062611.4

2000-12-15



DE10062611A

DE10062611A1
                          (en)
                      
2000-12-15
2000-12-15

  Skin oils from oil-soluble components and W / O emulsifiers with an HLB value of 2-6 and optionally one or more conventional additives, processes for their preparation and their use
 
       


PCT/EP2001/012707

WO2002047641A2
                          (en)
                      
2000-12-15
2001-11-02
Skin oils consisting of oil-soluble constituents 
       



Publications (1)



Publication Number
Publication Date





US20040067206A1
true
US20040067206A1
                       (en)
                   

2004-04-08





Family
ID=7667324
Family Applications (1)



Application Number
Title
Priority Date
Filing Date





US10/450,542
Abandoned

US20040067206A1
                          (en)
                      

2000-12-15
2001-11-02
Skin oils consisting of oil-soluble constituents and w/o-emulsifiers having an hlb value of between 2 and 6 and optionally at least one standard additive, method for the production thereof and use of the same 
       



Country Status (18)



Country
Link





US
                (1)
              



US20040067206A1
                  (en)
              



EP
                (1)
              
            


EP1363592B1
                  (en)
              



CN
                (1)
              
            


CN1481234A
                  (en)
              



AT
                (1)
              
            


AT303129T
                  (en)
              



AU
                (2)
              
            


AU2002212359B2
                  (en)
              



BG
                (1)
              
            


BG107875A
                  (en)
              



BR
                (1)
              
            


BR0116162A
                  (en)
              



CA
                (1)
              
            


CA2429536A1
                  (en)
              



CZ
                (1)
              
            


CZ20031646A3
                  (en)
              



DE
                (2)
              
            


DE10062611A1
                  (en)
              



EA
                (1)
              
            


EA200300680A1
                  (en)
              



EE
                (1)
              
            


EE200300290A
                  (en)
              



HU
                (1)
              
            


HU0302403A2
                  (en)
              



MX
                (1)
              
            


MXPA03005434A
                  (en)
              



NO
                (1)
              
            


NO20032662D0
                  (en)
              



PL
                (1)
              
            


PL361800A1
                  (en)
              



SK
                (1)
              
            


SK7432003A3
                  (en)
              



WO
                (1)
              
            


WO2002047641A2
                  (en)
              




Cited By (9)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US20060286053A1
              (en)
            
*

2005-06-20
2006-12-21
Playtex Products, Inc.
Non-irritating compositions 
       



ES2322122A1
              (en)
            
*

2009-02-10
2009-06-16
Laboratorios Starga S.L.
Cosmetic composition for the care and correction of telangiectasias 
       



US20090191248A1
              (en)
            
*

2008-01-30
2009-07-30
Kimberly-Clark Worldwide, Inc.
Hand health and hygiene system for hand health and infection control 
       



US8236287B2
              (en)
            

2010-09-03
2012-08-07
Neutrogena Corporation
Sunscreen compositions 
       



US20130046028A1
              (en)
            
*

2010-04-29
2013-02-21
Dow Corning Toray Co., Ltd.
Cosmetic Raw Material 
       



WO2012035468A3
              (en)
            
*

2010-09-14
2014-01-23
Trima - Israel Pharmaceutical Products Maabarot Ltd.
Foamable topical composition 
       



US20140080924A1
              (en)
            
*

2012-09-17
2014-03-20
Richard T. Rigg
Self-emulsifying and stabilizing gel for stabilizing cosmetic compositions 
       



US8697035B2
              (en)
            

2010-07-14
2014-04-15
Neutrogena Corporation
Skin care compositions 
       



US20190314268A1
              (en)
            
*

2018-04-17
2019-10-17
Clarence McGill
Mixture of Skin Oils 
       



Families Citing this family (10)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






DE10352371A1
              (en)
            
*

2003-11-10
2005-06-09
Beiersdorf Ag

  Use of hydrogenated soy glycerides in cosmetic preparations
 
       



DE102004008440A1
              (en)
            
*

2004-02-19
2005-09-22
Stockhausen Gmbh

  Cosmetic and / or dermatological agent for increasing the endogenous lipid content of the skin
 
       



DE102006053360A1
              (en)
            
*

2006-11-10
2008-05-15
Evonik Stockhausen Gmbh

  Skin cleansing preparations, in particular cold protection cream
 
       



FR2929849A1
              (en)
            
*

2008-04-11
2009-10-16
Brigitte Madeleine Michele Martin
Manufacturing of a massage oil, useful e.g. in the preparation of a composition to relax and to act against stress, comprises three successive steps for extraction carried out by slow and gentle cooking 
       



CN101766559B
              (en)
            
*

2009-01-07
2013-06-12
å´å¤©ç¥¥
Multifunctional skin protecting cream with functions of dispelling mosquitoes, relaxing muscles, stimulating blood circulation, preventing carsickness and the like 
       



RU2642672C2
              (en)
            
*

2012-06-28
2018-01-25
Ð¡Ð¸ÑÐµÐ¹Ð´Ð¾ ÐÐ¾Ð¼Ð¿Ð°Ð½Ð¸, ÐÑÐ´.
Inhibitor of hyaluronic acid decomposition including rosemary extract and retinol acetate 
       



DE202013103395U1
              (en)
            
*

2013-07-26
2013-08-13
Sasol Germany Gmbh

  Transparent sunscreen compositions and their use
 
       



CN105030608B
              (en)
            
*

2015-08-07
2017-08-25
å¹¿ä¸ä¸¸ç¾çç©ææ¯è¡ä»½æéå¬å¸
A kind of shoulder neck massage essential oils and preparation method and application 
       



CN105534756B
              (en)
            
*

2016-01-21
2017-08-25
å¹¿ä¸ä¸¸ç¾çç©ææ¯è¡ä»½æéå¬å¸
It is a kind of that there is not smooth compound essential oil of improvement qi and blood and preparation method thereof 
       



CN106511128A
              (en)
            
*

2016-10-28
2017-03-22
å¹¿å·çæ³åçç®¡çæéå¬å¸
Massage cream as well as preparation method and applications thereof 
       



Citations (7)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US5064644A
              (en)
            
*

1984-08-27
1991-11-12
Shiseido Company Ltd.
Water-in-oil emulsion type cosmetic composition 
       



US5234689A
              (en)
            
*

1990-11-08
1993-08-10
La Parfumerie, Inc.
Multi-purpose fragrance composition 
       



US5639450A
              (en)
            
*

1994-12-15
1997-06-17
Colgate-Palmolive Company
Cleansing and conditioning cosmetic composition 
       



US5665366A
              (en)
            
*

1993-09-15
1997-09-09
Elizabeth Arden Co., Division Of Conopco, Inc.
Skin care method and composition 
       



US5766628A
              (en)
            
*

1992-02-24
1998-06-16
Merz + Co. Gmbh & Co.
Bath and shower composition having vesicle-forming properties and method for the production and use thereof 
       



US5997888A
              (en)
            
*

1996-12-13
1999-12-07
Vesifact Ag
Cosmetic preparations 
       



US6667046B2
              (en)
            
*

1998-11-10
2003-12-23
Industria E Comercio De Cosmeticos Natura Ltda
Cosmetic water-in-silicone emulsion 
       



Family Cites Families (2)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






FR2492829B1
              (en)
            
*

1980-10-24
1983-06-24
Oreal




AU565628B2
              (en)
            
*

1984-04-11
1987-09-24
Unilever Plc
Skin treatment composition 
     





2000


2000-12-15
DE
DE10062611A
patent/DE10062611A1/en
not_active
Withdrawn




2001


2001-11-02
AT
AT01980539T
patent/AT303129T/en
not_active
IP Right Cessation


2001-11-02
CZ
CZ20031646A
patent/CZ20031646A3/en
unknown



2001-11-02
EA
EA200300680A
patent/EA200300680A1/en
unknown



2001-11-02
EP
EP01980539A
patent/EP1363592B1/en
not_active
Expired - Lifetime


2001-11-02
HU
HU0302403A
patent/HU0302403A2/en
unknown



2001-11-02
CA
CA002429536A
patent/CA2429536A1/en
not_active
Abandoned


2001-11-02
BR
BR0116162-8A
patent/BR0116162A/en
not_active
IP Right Cessation


2001-11-02
PL
PL01361800A
patent/PL361800A1/en
not_active
Application Discontinuation


2001-11-02
MX
MXPA03005434A
patent/MXPA03005434A/en
unknown



2001-11-02
US
US10/450,542
patent/US20040067206A1/en
not_active
Abandoned



2001-11-02
SK
SK743-2003A
patent/SK7432003A3/en
unknown



2001-11-02
CN
CNA018205550A
patent/CN1481234A/en
active
Pending


2001-11-02
DE
DE50107319T
patent/DE50107319D1/en
not_active
Expired - Lifetime


2001-11-02
AU
AU2002212359A
patent/AU2002212359B2/en
not_active
Ceased


2001-11-02
AU
AU1235902A
patent/AU1235902A/en
active
Pending


2001-11-02
EE
EEP200300290A
patent/EE200300290A/en
unknown



2001-11-02
WO
PCT/EP2001/012707
patent/WO2002047641A2/en
not_active
Application Discontinuation




2003


2003-06-04
BG
BG107875A
patent/BG107875A/en
unknown



2003-06-12
NO
NO20032662A
patent/NO20032662D0/en
unknown







Patent Citations (7)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US5064644A
              (en)
            
*

1984-08-27
1991-11-12
Shiseido Company Ltd.
Water-in-oil emulsion type cosmetic composition 
       



US5234689A
              (en)
            
*

1990-11-08
1993-08-10
La Parfumerie, Inc.
Multi-purpose fragrance composition 
       



US5766628A
              (en)
            
*

1992-02-24
1998-06-16
Merz + Co. Gmbh & Co.
Bath and shower composition having vesicle-forming properties and method for the production and use thereof 
       



US5665366A
              (en)
            
*

1993-09-15
1997-09-09
Elizabeth Arden Co., Division Of Conopco, Inc.
Skin care method and composition 
       



US5639450A
              (en)
            
*

1994-12-15
1997-06-17
Colgate-Palmolive Company
Cleansing and conditioning cosmetic composition 
       



US5997888A
              (en)
            
*

1996-12-13
1999-12-07
Vesifact Ag
Cosmetic preparations 
       



US6667046B2
              (en)
            
*

1998-11-10
2003-12-23
Industria E Comercio De Cosmeticos Natura Ltda
Cosmetic water-in-silicone emulsion 
       




Cited By (14)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US20100226867A1
            (en)
          
*

2005-06-20
2010-09-09
Dueva-Koganov Olga V
Non-irritating compositions 
       



US7910090B2
            (en)
          

2005-06-20
2011-03-22
Playtex Products, Inc.
Non-irritating compositions 
       



US20060286053A1
            (en)
          
*

2005-06-20
2006-12-21
Playtex Products, Inc.
Non-irritating compositions 
       



US9067083B2
            (en)
          

2005-06-20
2015-06-30
Eveready Battery Company, Inc
Non-irritating compositions 
       



US20090191248A1
            (en)
          
*

2008-01-30
2009-07-30
Kimberly-Clark Worldwide, Inc.
Hand health and hygiene system for hand health and infection control 
       



US10589134B2
            (en)
          
*

2008-01-30
2020-03-17
Kimberly-Clark Worldwide, Inc.
Hand health and hygiene system for hand health and infection control 
       



ES2322122A1
            (en)
          
*

2009-02-10
2009-06-16
Laboratorios Starga S.L.
Cosmetic composition for the care and correction of telangiectasias 
       



WO2010092198A1
            (en)
          
*

2009-02-10
2010-08-19
Laboratorios Starga, S.L.
Cosmetic composition for the care and correction of telangiectasias 
       



US20130046028A1
            (en)
          
*

2010-04-29
2013-02-21
Dow Corning Toray Co., Ltd.
Cosmetic Raw Material 
       



US8697035B2
            (en)
          

2010-07-14
2014-04-15
Neutrogena Corporation
Skin care compositions 
       



US8236287B2
            (en)
          

2010-09-03
2012-08-07
Neutrogena Corporation
Sunscreen compositions 
       



WO2012035468A3
            (en)
          
*

2010-09-14
2014-01-23
Trima - Israel Pharmaceutical Products Maabarot Ltd.
Foamable topical composition 
       



US20140080924A1
            (en)
          
*

2012-09-17
2014-03-20
Richard T. Rigg
Self-emulsifying and stabilizing gel for stabilizing cosmetic compositions 
       



US20190314268A1
            (en)
          
*

2018-04-17
2019-10-17
Clarence McGill
Mixture of Skin Oils 
       




Also Published As



Publication number
Publication date






EE200300290A
              (en)
            

2003-10-15



CN1481234A
              (en)
            

2004-03-10



NO20032662D0
              (en)
            

2003-06-12



WO2002047641A3
              (en)
            

2002-12-12



CA2429536A1
              (en)
            

2002-06-20



MXPA03005434A
              (en)
            

2005-02-14



DE50107319D1
              (en)
            

2005-10-06



BG107875A
              (en)
            

2004-01-30



BR0116162A
              (en)
            

2003-10-14



PL361800A1
              (en)
            

2004-10-04



HU0302403A2
              (en)
            

2003-10-28



AT303129T
              (en)
            

2005-09-15



NO20032662L
              (en)
            

2003-06-12



EA200300680A1
              (en)
            

2004-04-29



EP1363592B1
              (en)
            

2005-08-31



AU1235902A
              (en)
            

2002-06-24



AU2002212359B2
              (en)
            

2004-07-08



DE10062611A1
              (en)
            

2002-06-27



SK7432003A3
              (en)
            

2003-09-11



CZ20031646A3
              (en)
            

2003-09-17



EP1363592A2
              (en)
            

2003-11-26



WO2002047641A2
              (en)
            

2002-06-20





Similar Documents



Publication
Publication Date
Title







US20040076652A1
                (en)
              


2004-04-22

Vesicle forming skin oils comprising w/o-emusifiers with an hydrophilic-lipophilic balance of 2-6, method for the production and the use thereof 
       




AU2002212359B2
                (en)
              


2004-07-08

Skin oils consisting of oil-soluble constituents 
       




JP6843620B2
                (en)
              


2021-03-17


  Composition for application to skin for reducing adhesion of contaminated particles on skin and method for preparing the same
 
     




US8268335B2
                (en)
              


2012-09-18

Skin treatment systems 
       




JP5802057B2
                (en)
              


2015-10-28


  Oil-in-water emulsified cosmetic
 
     




EP1049452A2
                (en)
              


2000-11-08

Reduced lipid flowable cosmetic or dermatological preparations 
       




US6858200B2
                (en)
              


2005-02-22

Sunscreen formulations 
       




EP2923736B1
                (en)
              


2018-01-10

Method of making an anhydrous, pigmented composition 
       




EP1641904A2
                (en)
              


2006-04-05

O/w emulsifier, o/w emulsion and applications thereof 
       




WO1999065599A1
                (en)
              


1999-12-23

Flowable preparations of the water-in-oil emulsion type having an increased water content 
       




WO2017133822A1
                (en)
              


2017-08-10

Water-in-oil emulsions which are based on cetyl diglyceryl tris(trimethylsiloxy)silyl ethyl dimethicone as emulsifier and are largely silicone oil-free 
       




EP3658104A1
                (en)
              


2020-06-03

Water-in-oil emulsions which are based on cetyl diglyceryl tris(trimethylsiloxy)silyl ethyl dimethicones as emulsifier and contain aromates 
       




DE19920839A1
                (en)
              


2000-12-07


  Flowable preparations of emulsion type W / O with increased water content with a content of medium polar lipids
 
       




KR20200139252A
                (en)
              


2020-12-11


  New composite and emulsion composition
 
     




WO2016087166A1
                (en)
              


2016-06-09

Cosmetic and dermatological preparations in the form of water-in-silicone oil emulsions, containing bis-(glyceryl/lauryl) glyceryl/lauryl dimethicone and dehydroacetic acid 
       




JP2023504697A
                (en)
              


2023-02-06


  Cosmetic compositions and uses thereof, and methods for improving sensory properties
 
     




WO2016087167A1
                (en)
              


2016-06-09

Cosmetic and dermatological preparations in the form of water-in-silicone oil emulsions, containing bis-(glyceryl/lauryl) glyceryl/lauryl dimethicone and levulinic acid 
       




WO2016087165A1
                (en)
              


2016-06-09

Cosmetic and dermatological preparations in the form of water-in-silicone oil emulsions, containing bis-(glyceryl/lauryl) glyceryl/lauryl dimethicone, and one or more acyl glutamates 
       





Legal Events



Date
Code
Title
Description




2003-10-31
AS
Assignment


Owner name:
              MERZ PHARMA GMBH & CO. KGAA, GERMANY


Free format text:
              ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PASPALEEVA-KUHN, VALENTINA;SCHATSCHNEIDER, SIMONE;BEUTLER, ROLF;REEL/FRAME:014655/0081


Effective date:
              20030820




2007-12-07
STCB
Information on status: application discontinuation


Free format text:
              ABANDONED  --  FAILURE TO RESPOND TO AN OFFICE ACTION














